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Abstract 
 
 Brain functions, such as learning, orchestrating locomotion, memory recall, and 
processing information, all require glucose as a source of energy.  During these functions, 
the glucose concentration decreases as the glucose is being consumed by brain cells.  By 
measuring this drop in concentration, it is possible to determine which parts of the brain 
are used during specific functions and consequently, how much energy the brain requires 
to complete the function.  One way to measure in vivo brain glucose levels is with a 
microdialysis probe.  The drawback of this analytical procedure, as with many steady-
state fluid flow systems, is that the probe fluid will not reach equilibrium with the brain 
fluid.  Therefore, brain concentration is inferred by taking samples at multiple inlet 
glucose concentrations and finding a point of convergence.  The goal of this thesis is to 
create a three-dimensional, time-dependent, finite element representation of the brain-
probe system in COMSOL 4.2 that describes the diffusion and convection of glucose.  
Once validated with experimental results, this model can then be used to test parameters 
that experiments cannot access.  When simulations were run using published values for 
physical constants (i.e. diffusivities, density and viscosity), the resulting glucose model 
concentrations were within the error of the experimental data.  This verifies that the 
model is an accurate representation of the physical system. 
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 In addition to accurately describing the experimental brain-probe system, the 
model I created is able to show the validity of zero-net-flux for a given experiment.  A 
useful discovery is that the slope of the zero-net-flux line is dependent on perfusate flow 
rate and diffusion coefficients, but it is independent of brain glucose concentrations.  The 
model was simplified with the realization that the perfusate is at thermal equilibrium with 
the brain throughout the active region of the probe.  This allowed for the assumption that 
all model parameters are temperature independent.  The time to steady-state for the probe 
is approximately one minute.  However, the signal degrades in the exit tubing due to 
Taylor dispersion, on the order of two minutes for two meters of tubing.  Given an 
analytical instrument requiring a five μL aliquot, the smallest brain process measurable 
for this system is 13 minutes. 
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1 Introduction 
 
Brain functions, such as learning, orchestrating locomotion, recalling memory, 
coping with stress and processing information, all require glucose as a source of energy.1  
During these functions, there are localized drops in glucose concentration in the areas of 
the brain being used.  By measuring the drop in glucose concentration, it is possible to 
determine which parts of the brain are used during specific functions and consequently, 
how much energy the brain requires to complete that function.  One way to measure 
glucose levels in the brain is with a microdialysis probe.  Most recently, microdialysis has 
been used to study animal behavior, seizures, insulin-induced hypoglycemia, 
transplantations, neurotransmitters and pharmacology.2,3
A microdialysis probe is essentially a needle with a semipermeable membrane 
covering the tip.  When the probe is inserted into the brain, a fluid almost identical to 
brain fluid, known as the perfusate, is perfused though the probe.  The perfusate enters 
the probe at the top and flows down the center.  It then passes through two small bore 
holes near the base of the probe into the outer annulus, which is the active region.  The 
fluid also exits the probe at the top.  The only difference between the brain fluid and the 
perfusate is the concentration of glucose.  This creates a concentration gradient across the 
membrane, and glucose diffuses from the fluid of higher concentration to the fluid of 
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lower concentration to reduce the gradient.  Figure 1 shows the case in which the 
concentration of glucose in the perfusate is less than that of the brain. 
 
 
 
 
Figure 1. Schematic of brain-probe system. 
 
The drawback of this analytical procedure, as with many steady-state fluid flow 
systems, is that the perfusate will exit the probe before it can reach chemical equilibrium 
with the brain fluid.  Therefore, brain concentration is inferred by taking samples at 
multiple inlet glucose concentrations and finding a point of convergence.  This is called 
the Zero-Net-Flux (ZNF) method because the brain concentration is calculated by 
realizing there is no net flux of glucose when the perfusate is at equilibrium with the 
brain fluid.4 
From reservoir To analyzer 
Diffusion of 
glucose 
Membrane Brain 
space 
Fluid 
flow 
3 
 
 
 
 A two-dimensional, axisymmetric finite element representation of a microdialysis 
brain-probe system was created in COMSOL 4.2.  This model accurately describes the 
diffusion and convection of glucose in the brain-probe system.  The overall goal was to 
use this model to validate assumptions made in the analysis of experimental results.5
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2 Hypothesis 
 
In the proposed work, I tested the following two hypotheses: 
 
 Current assumptions made in analyzing microdialysis data using ZNF are 
accurate. 
 Application of the ZNF method rests on several assumptions that are not 
experimentally assessable in vivo.  I believe that by creating a three-dimensional finite 
element model of the brain-probe system I can validate all assumptions made using ZNF.  
I also believe that the wait time between microdialysis trails is less than 15 minutes, 
which is the current standard. 
 With a working model I can test other experimental areas previously inaccessible 
such as temperature dependence, parameter sensitivity and reverse microdialysis. 
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 Dilution of signal concentration in the outlet perfusate tubing is the limiting 
factor in temporal resolution. 
 The microdialysis probe is only between two to four millimeters in length, but is 
followed by up to two meters of tubing before samples are collected.  It is possible that 
Taylor dispersion significantly reduces the difference between nominal brain 
concentration and the concentration during an observed brain process.  This is another 
area that is accessible by model but not in vivo.
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3 Background 
 
 In order to understand how to create an accurate model, it is necessary to have an 
understanding of dialysis, mass transport and basic brain physiology.  In the following 
sections, some of the basics of these concepts are described. 
 
3.1 Motivation 
 
 One of the major fields of study in neurology today is the connection between 
glucose concentration in the brain and brain functions, such as learning and 
memorization.4  The problem that neurologists face is that brain glucose concentration 
cannot be measured directly.  In the search for an indirect form of brain measurements, 
the method of microdialysis was developed.  ZNF is one method used for calibrating 
output measurements to actual brain concentrations.4  
 When using ZNF, neurologists perfuse a microdialysis probe with a range of 
different glucose concentrations and record the outlet concentration.  When the net 
change in glucose concentration through the probe is plotted against inlet concentration, a 
linear trend is observed.  The point at which the line of best fit crosses the x-axis is the 
concentration of glucose in the brain, because it is at this point that there is not flux 
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across the probe, i.e. no concentration gradient. This concept is shown graphically in 
Figure 2. 
 
 
Figure 2. Zero net flux.  Probe is perfused at multiple analyte 
concentrations (Cin, x-axis) and plotted against net flux of analyte across 
the membrane (Cout-Cin, y-axis).  If ZNF is valid, the points can be fit by 
a line and the x-intercept is brain concentration. 
 
 In theory, ZNF is a reliable and efficient means of measuring brain concentration.  
However, the ZNF method is based on certain important transport assumptions which 
cannot be demonstrated experimentally due to the complexity of a living system. 
 By modeling the brain-probe system using finite element analysis, it will be 
possible to define all of the system’s unknown parameters.  If the model accurately 
predicts experimental results, then it may be inferred that ZNF assumptions are 
reasonable and measurements gained from ZNF readings can be assumed to be accurate. 
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3.2 Microdialysis 
 
3.2.1 History 
 
 Microdialysis was first developed in the 1960s to characterize interstitial water in 
dog brains.  One of the earliest units was a dialysis sac, in which a membrane was placed 
in the brain and allowed to sit for an extended period of time.  It was assumed that by the 
time the sac was removed, the contents had come to equilibrium with the extracellular 
fluid (ECF) in the brain.6  In 1972, Delgado and Defeudis first reported the use of a probe 
and technique that caused significantly less tissue disruption than in previous studies.7  
The next breakthrough in microdialysis came in 1974 when Ungerstedt and Pycock 
reported using “hollow fibers” to infer ECF concentrations.  The hollow fibers were 
tubular semipermeable membranes measuring 200-300 μm in diameter.8  Today, the most 
widely-used probe is a needle with membrane covering only the tip of the unit. 9
 Within the category of membrane needle microdialysis, there are four main probe 
configurations (
 
Figure 3).10  In a transversal probe, the inlet and outlet streams are on 
opposite sides of the membrane.  This geometry is used mostly for measuring superficial 
brain structures.  Loop, side-by-side, and concentric geometries are in a category of 
microdialysis called vertical probes.  Vertical probes are most commonly used in research 
today; selecting one over the other comes down to preference.11
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Figure 3. Basic geometry for four common microdialysis designs. (A) 
transversal, (B) loop, (C) side-by-side and (D) concentric.10  
 
 The majority of microdialysis probes are made of stainless steel or fused silica 
tubing with a 1 to 4 mm length of semipermeable membrane at the tip.  Probes can either 
be implanted permanently or inserted temporarily into tissue or bone using a permanent 
guide cannula.10  
 
3.2.2 Microdialysis Probe Used in This Project 
 
 In this project, a CMA 12 microdialysis probe (Figure 4) was modeled.  This 
specific probe used has a concentric geometry with a stainless steel casing and a 3 mm 
length of 20 kDa cutoff polycarbonate membrane at the tip.5  While CMA reports 
membrane thickness to be 25 μm, many experiments have reported swelling of the 
membrane in situ.  Rosenbloom et al. reported a membrane thickness of 40 μm using a 
scanning electron microscope (SEM).12 
10 
 
 
 
 
Figure 4. CMA 12 microdialysis probe13
 
 
3.3 Brain Physiology 
 
 While it is not within the scope of this thesis to fully explore the physiology of the 
brain, it is imperative to have a general grasp of related topics such as brain structure and 
metabolic supply.14
 Brain cells produce energy necessary for functioning by metabolizing glucose 
found in the ECF; sufficient oxygen is needed for cells to utilize their most efficient 
metabolic pathway.
 
15
Figure 5
  Glucose is carried from the stomach to the brain in the blood 
stream and is transported to brain tissue via capillaries.   is a simple diagram of 
the brain-probe system in which the center rectangle is the probe.2  The brain itself is 
composed mostly of neurons (white circles) and glial cells (black circles).16  Glial cells 
provide structure for neurons and help regulate molecules available to neurons in the 
ECF.17
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Figure 5. Diffusion of glucose (arrows) from the capillaries (red lines) to 
the probe (central rectangle).  The white circles represent neurons and the 
black circles represent glial cells.2 
 
 The transport of glucose (arrows) from the capillaries (red lines) to the probe is 
impeded by the brain cells.  As can be seen in Figure 5, glucose has to physically travel 
around the cells, which increases the length of the diffusion pathway.  However, these 
cells cannot simply be considered as physical diffusion inhibitors, as neuron and glial 
cells are constantly consuming glucose.  The amount of glucose consumed by the cells is 
dependent on the current neurological activity.2  
 Capillaries, on average, are equally spaced and evenly distributed throughout the 
brain.  Due to the relative rates of oxygen diffusion and consumption in the brain, oxygen 
is almost entirely consumed by the time it reaches any distance 25 µm from the capillary.  
Because no cell could survive outside of 25 µm from a capillary, capillaries are always 
found within 50 µm of each other in healthy or normal brain tissue.14 
  
50 μm 
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3.4 Transport of Glucose 
 
3.4.1 Transport model for Probe-Brain System 
 
 The transport of glucose in the brain-probe system is based on two governing 
differential equations: Navier-Stokes (Equation 1) and the conservation of mass 
(Equation 4). 
 𝜌 �𝜕𝑣�⃗
𝜕𝑡
+ ?⃗? ∙ ∇?⃗?� = −∇𝑝 + 𝜇∇2?⃗? + 𝑓 (1) 
 Navier-Stokes models the motion of a fluid and works best with laminar flow 
(Re<2000).  The first term represents the unsteady-state acceleration of the flow while the 
second term is convective acceleration.  The third and fourth terms represent the pressure 
gradient and stress, respectively.  The fifth encompasses external forces such as gravity 
and electromagnetism; these forces can be assumed to be negligible in the small brain-
probe system.  Navier-Stokes is used to model only the flow of the perfusate, as there is 
no bulk flow in the membrane and brain. 
 For the given microdialysis unit, the Reynolds number  
 𝑅𝑒 = 𝜌𝑤𝑎𝑣
𝜇
 (2) 
is on the order of 0.02, which qualifies it for Stoke’s (or creeping) flow (Re«1).18  In 
creep flow, the inertial terms are negligible, which allows for a much simpler differential 
equation 
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 𝜌 𝑑𝑣�⃗
𝑑𝑡
= −∇𝑝 +  𝜇∇2?⃗?. (3) 
Equation 3 will be used to describe the flow of perfusate through the microdialysis 
probe.18 
 The conservation of mass equation  
 𝑑𝑐
𝑑𝑡
+ ∇ ∙ (𝐷∇𝑐) = −?⃗? ∙ ∇𝑐 (4) 
 describes the transport of material by both convection and diffusion.  It will be used to 
simulate the diffusion of glucose from the brain, through the membrane, and into the 
perfusate, as well as the convection of the glucose within the perfusate.  The first term 
represents the unsteady-state change in concentration.  The second term represents the 
diffusion due to a concentration gradient, while the third term represents the transport due 
to convection. 
 Equation 4 is only accurate if Fickian diffusion applies to this system.  Fickian 
diffusion assumes that diffusion is independent of the magnitude of the concentration and 
that there is no bulk flow of material in the brain and through the membrane.  At the 
dilute concentrations used in this thesis, diffusion is dependent solely on the 
concentration gradient, not the magnitude of the concentration.  Bulk flow through the 
pores of the membrane could occur for two reasons, extremely high concentration or 
pressure gradients.  If the concentration gradient is too large, and diffusion therefore too 
fast, the glucose can actually pull water along with it through the membrane and create 
bulk flow.  The concentration gradients in this thesis are not large enough to induce bulk 
flow.  If the aECF is not identical to the brain composition, other ions may diffuse across 
14 
 
 
 
the membrane as well.  However, as long as these gradients are kept small, the diffusion 
of glucose will be independent from the diffusion of other components. 
 If the pressure gradient across the membrane is too large water will be forced 
through the probe.  The minimum pressure in the probe needed to induce flow is 6.2 kPa; 
this is based on the radius and length of exit tubing connecting the probe and the 
analytical instrument.18  Normal blood pressure in a rat brain is 17.2 kPa.19
 The biggest, most consequential assumption made in this model is that the system 
can be described using continuum mechanics.  Continuum mechanics is the analysis of 
materials modeled as a continuous material rather than as discrete particles.  It is the 
assumption that this model is describing the system on a scale large enough to consider 
behaviors of and interactions between individual molecules negligible compared to the 
behavior of the material as a whole.  Equations 1-4 are only valid in the field of 
continuum mechanics.  Above, the brain is described as a non-homogonous, non-
continuous material.  Later this description will be adjusted in order to approximate the 
brain as a continuous material for use in modeling. 
  This 
difference is not large enough to induce bulk flow of water. 
 Boundary and initial conditions for Equations 3 and 4 are defined in Appendix A. 
 
3.4.2 Transport Model for Post-Probe Tubing 
 
 In addition to modeling the transport of glucose from the brain to the perfusate, 
the transport of glucose from the probe to the detector was also modeled.  When 
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conducting in vivo microdialysis, it is imperative to create an environment free from 
stress for the rat specimens.  To achieve this, the rats need to be able to move around 
freely within an area, unhampered by testing equipment.  For this to happen, the tubing 
that delivers the perfusate from the probe to the glucose detector must be of considerable 
length.  With glucose traveling in creep flow and tubing of up to two meters in length, 
perfusate can take as long as an hour to reach the detector.20
 
  As perfusate flows down the 
tubing, glucose is diffusing both radially and linearly.  If the tubing is too long or the 
flow rate is too small, signal strength will degrade due to Taylor dispersion.  If too much 
dispersion occurs, the signal will be indistinguishable from nominal concentration and 
will therefore be undetectable.  The minimum signal duration (i.e. time of thought) that 
can be detected by an analytical instrument will therefore be determined. 
3.5 Prior Work 
 
 Due to the many uses microdialysis has in a variety of fields, it has been studied 
and approached both theoretically and numerically in many previous works.  While this 
model draws on previous work, the work shown here adds further insight and 
development to the field of microdialysis.21
 Lindefors and Amberg crafted a massively complex and mechanistic function that 
is based on in vitro data and detailed system parameters.
 
22  The function is theoretically 
sound, but is too detailed for repeated use.  A simple and quick model based on first 
principles and easily determined in vivo parameters was able to be created. 
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3.5.1 Calibrating In Vitro 
 
 The first attempts at characterizing outlet concentrations were geared towards 
correlating a calibration between in vitro and in vivo measurements. This approach 
assumed that the transport of glucose from a non-stirred beaker solution to the probe 
would be the same as the transport from the brain to the probe, or at least that a simple 
relationship existed between them.23
 Benveniste attempted to amend Zetterström’s equations to fit empirical data.
  Zetterström et al. quickly realized that the brain is 
significantly more complex than a solution in a beaker and that in vivo measurements 
could not be inferred from in vitro data.   
2  
However, Benveniste was only able to accurately represent a few substances, mainly 
ions.  When Benveniste tried to account for molecules involved in uptake mechanisms, 
errors in the calculations increased.  For this reason, this model describes an in vivo 
system.  The brain is simplified to facilitate continuum mechanics; the model still reflects 
the real system close enough to produce accurate results.  While Benveniste and 
Zetterström modeled probes of the loop design (Figure 3.B), this model describes a probe 
with a concentric geometry (Figure 3.D). 
 
3.5.2 Flow Rate Based Models 
 
 An alternative approach to zero-net-flux is zero flow.  In 1985, Jacobson et al. 
proposed a method based on the principal of zero flow dialysis.24  This technique 
17 
 
 
 
involves a membrane sac filled with aECF (artificial extracellular fluid) being placed in 
the brain for an extended period of time, allowing the aECF to reach equilibrium with the 
brain.6  Jacobson used needle probes and recorded outlet concentrations at a variety of 
flow rates.  He then extrapolated this data back to a flow rate of zero.  The problem with 
this approach is the concentration has an exponential term, and therefore asymptotic, 
profile as the flow rate approaches zero.  The ZNF system and this model are based on 
well-defined, linear interpolation as opposed to sensitive, asymptotic extrapolation.  
Jacobson’s model is based on the geometry of a simple annulus. 
 Bungay et al. furthered Jacobson’s work and, in doing so, developed the first 
model to incorporate active biological processes.25
 
  Unfortunately, Bungay’s model is too 
detailed and requires knowledge of parameters that cannot be determined experimentally.  
The model is therefore based on assumptions and estimated parameters.   
3.5.3 Numerical Models 
 
 As computing power increases and becomes more accessible, researchers are 
turning to numerical modeling to describe the microdialysis systems.  Norton et al. and 
Wang et al. both used a modeling program called COMSOL to describe the probe.26,27
Figure 3
  
However, both models only described the probe in vitro.  This paper will present the first 
numerical model of an in vivo microdialysis system.  As with Jacobson, Norton’s model 
is designed around an annular geometry, while Wang described a side-by-side probe 
( .C).
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4 Materials and Methods 
 
4.1 Finite Element Method 
 
 The finite element method (FEM) was born out of the need for accurate and 
efficient approximate solutions.  First popularized in the 1960s, FEM was used to study 
stresses in complex aircraft structures.28
 In a continuum mechanics problem, such as diffusion of glucose through a 
membrane, the domain is made up of an infinite number of values, and therefore the 
problem has an infinite number of unknowns.
  Since then, the simplicity and effectiveness of 
FEM has allowed it to spread to every aspect of continuum mechanics. 
28  FEM is essentially the breaking up of a 
single complex differential system into many simpler problems.29  The overall solution 
domain is segmented into smaller subdomains called finite elements.30
31
  Each element is 
assumed to be solvable using a simple function that can accurately approximate the real 
system.  These approximate solutions are called trial functions.   Each element has a 
number of nodes on their boundary which act as local boundary conditions.  By 
connecting a finite number of elements, defined by nodes and internally approximated by 
trial functions, a highly complex system can be easily and efficiently approximated with 
reasonable accuracy.28 
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 A good way to visualize FEM is by considering a simplified system, such as the 
linear transfer of heat through a metal rod.30  The temperature profile in Figure 6 could 
easily be modeled by a third order function, but for the sake of the example, assume no 
exact solution can be found.  The first step of FEM is to break the domain into 
subdomains and create what is called a mesh, as in Figure 7.  In this example, the rod is 
divided into two subdomains, with a boundary across the middle of the rod.  As can be 
seen, each element can now be approximated by a parabolic equation (T=a1+a2x+a3x2).  If 
there are two parabolic equations, with two unknown constants each, there are four 
unknowns.  In FEM, these four constants are iterated until boundary conditions are met 
and the approximation of the temperature profile is within a set tolerance. 
 
 
 
Figure 6. Temperature profile down the length of a metal rod. 
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Figure 7. Temperature profile down the length of a metal rod discretized 
into two finite elements. 
 
 The first major decision that needs to be made is selecting the mesh, or deciding 
how to break up the system and is covered below.  Once an appropriate mesh has been 
selected, a trial function has to be selected.  Trial functions are usually polynomials 
because they are easy to integrate and differentiate.28  The order of the polynomial is 
dependent on the number of parameters being solved for and the number of nodes on an 
element.   
 𝑦𝑎  =  𝑦𝑜(𝑥)  + ∑ 𝑎𝑗𝑥2(𝑗−1)(1 − 𝑥2)𝑁𝑗=1  (5) 
is a commonly used trial function, especially for profiles of symmetric shape.31
 Next, the governing differential equation is set equal to zero and inserted into 
Equation 
   
5.  If Equation 5 is the analytical solution to the problem, then inserting it into 
the governing differential equation will produce a value of zero.  However, if Equation 5 
is only an approximate solution, which is usually the case, then a value will be produced 
that is dependent on x.  This value is called the residual and is represented by Rerr.28  
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From this point onward, the coefficients aj would be continually adjusted until the 
residual is within an allowable tolerance.  However, in the residual’s current state, the 
value is dependent on the location in the system it is being sampled; therefore, 
comparison between residuals would be difficult.  It is therefore necessary to average the 
residual function.  One way to carry this out is to take the inner product of the trial 
function with another function, called the test function.28  The selection of the test 
function is as important as selecting the trial function as it dictates which form of the trial 
function is most accurate.  Many methods have been derived to select appropriate test 
functions, the most notable being collocation, subdomain, least squares, moment, and 
Galerkin.28 
 As the Galerkin method is the most commonly used method in fluid mechanics 
and diffusion problems, it will be the focus of this background.  In this method, the test 
function is selected from the same family of functions as the trial function.  In the case of 
Equation 5, a reasonable test function would be 
 
 𝑤𝑘  =  (1 −  𝑥2). (6) 
 
 To find the inner product of two functions, they are simply multiplied and then 
integrated over the domain, as in  
 
 (𝑅𝑒𝑟𝑟 ,𝑤𝑘)  =  ∫ 𝑅𝑤𝑘 𝑑𝑥+𝑥−𝑥 . (7) 
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 Now sets of coefficients can be easily compared using the residual and the trial 
function can be optimized.  Once an accurate trial function has been established for each 
finite element, the elements can be put back together to form a cohesive single solution 
domain.  For efficiency purposes, COMSOL will be used to do the computing. 
 
4.2 System Parameters and Boundary Conditions 
 
 In reality, the path of diffusion of glucose from a blood vessel to a probe is 
impeded both physically and chemically by brain cells.  Not all of the glucose that leaves 
the blood vessel makes it to the probe; some of the glucose is absorbed by brain cells.  
The glucose that does make it to the probe does not diffuse there in a straight line; it has 
to move around the brain cells (Figure 5).  The diffusion path is thus influenced by 
tortuosity (λ).  The more tortuous the paths in a material are, the longer a molecule’s path 
is to travel from one point to another.  To accurately approximate the brain as a 
continuous material, all of these factors can be combined with the constant of free 
diffusion of glucose in ECF (DECF) to produce an effective diffusion coefficient (De,B) 
 𝐷𝑒,𝐵  =  𝐷𝐸𝐶𝐹𝜙𝑒𝜆2  (8) 
which describes the relationship between effective diffusion, free diffusion, void fraction 
(ϕe) and tortuosity.
18 
 Equation 8 also describes the effective diffusivity in the membrane.  However, 
because knowing the effective diffusivity is imperative for most membrane experiments, 
this constant has been found experimentally for a number of membranes and molecules, 
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including the diffusion of glucose through pores in polycarbonate.  This experimental 
value will be used in preference to a calculated value.32
 All parameters use in this simulation are summarized in 
 
Table 1.  Note that the 
“outer boundary” concentration is being modeled at the outer wall of a capillary. This 
concentration is the model’s “true” ECF glucose concentration, the concentration that 
ZNF is used to determine.  
  
Table 1. Physical parameters for brain-probe system. 
Variable Expression Value Units Ref 
V Volumetric flow rate of perfusate 1.67x10-11 m3/s 5 
c0P 
Initial glucose concentration in 
perfusate/membrane 0.50 mol/m
3 
5 
c0B Initial glucose concentration in brain 1.25 mol/m3 
5 
hm Height of Membrane 3.00x10-3 m 
5 
cc 
Outer capillary (brain) glucose 
concentration 1.25 mol/m
3 
5 
wm Membrane thickness 4.00x10-5 m 
12 
wb Width of brain section 5.00x10-5 m 
15 
rhoP Density of Perfusate 9.90x102 kg/m3 
33 
etaP Dynamic Viscosity of Perfusate 7.28x10-4 Pa s 
33 
DP 
Diffusion Coefficient of glucose 
 in Perfusate 8.30x10
-10 m2/s 
33 
DB 
Diffusion Coefficient of glucose 
 in Brain 1.16x10
-10 m2/s 
2,35 
DM 
Diffusion Coefficient of glucose 
 in Membrane 7.62x10
-11 m2/s 
32 
 
 Values for volumetric flow rate, initial perfusate/membrane and brain 
concentrations, membrane length, and outer boundary concentrations are the 
specifications and results of McNay’s research.5  This is the experiment used to provide a 
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dataset to confirm the accuracy of the simulation.  The width of the membrane and brain 
are justified in the Background.  Density, viscosity and perfusate diffusivity are 
calculated using the PRSV (the Stryjek-Vera modification of the Peng-Robinson equation 
of state) model at 38.2°C.33,34
8
  The value for brain diffusivity is calculated using Equation 
 with 0.35 as the volume fraction of ECF in brain and 1.6 as the tortuosity factor.35 2,  
 
4.3 Construction of Model 
 
 COMSOL 4.2, a FEM program, will be the main program used to model the 
brain-probe system.  COMSOL stores linear equations in the form Ax=b and then uses a 
method called generalized minimal residual (GMRES) to solve the equations.  GMRES is 
an iterative method which follows the general method outlined above.36
 
 
4.4 Mesh 
 
 One of the most important decisions in using FEM software is selecting the mesh 
size.  The mesh is what defines where calculations are conducted and how many degrees 
of freedom there will be.  If a coarse mesh is selected, the solution will likely not be 
accurate because calculations are only taken at a few points.  However, if the mesh is too 
fine, it will take too long for the program to compute results, and no solution will be 
reached.  Another decision that has to be made is mesh shape.  In a three-dimensional 
model, the mesh can take any form; however, the most common shapes are either 
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quadrilaterals or tetrahedra.  Quadrilaterals are better suited for boxy geometries while 
tetrahedra are better suited for round geometries, such as spheres and cylinders.  
Similarly, the most common mesh shapes in two-dimensional modeling are quadrilaterals 
and triangles. 
 Therefore, once a mesh shape has been selected, a balance must be struck. The 
mesh must be fine enough that the solution is accurate, yet coarse enough that the 
computer can provide a solution in a timely manner. 
 
4.5 Data Processing 
 
 Because most laboratories using microdialysis only record outlet glucose 
concentration, this is the only piece of data needed to be tracked during simulation to 
verify ZNF.  This is accomplished by integrating the concentration of glucose over the 
surface of the outlet channel, generated directly by COMSOL.
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5 Results 
 
5.1 Model Image/Drawing 
 
5.1.1 Three-Dimensional (Asymmetric) Model 
 
 A three-dimensional model of the brain-probe system, as described in the 
Background, was constructed using COMSOL 4.2.  Three dimensions were used as a 
starting point because in addition to radial and axial transport, there is angular diffusion 
caused by the two bore holes connecting the inner cannula to the outer annulus.  None of 
these three directional flows seemed negligible. 
 Figure 8 shows the overall (A) and cutaway (B) geometry of the system being 
modeled.  The cutaway model shows the inlet perfusate channel (a), the outlet perfusate 
channel (c), the membrane (d), and the brain layer (e).  The gap that separates the inlet 
and outlet channels (b), as well as the gap between the base of the flow regime and the 
bottom brain layer (g), are stainless steel and have no interaction with the system, so they 
are not modeled (i.e. an empty space).  In the cutaway model, the two tubes that connect 
the inlet and outlet perfusate channels can be seen, as well as the layer of brain beneath 
the probe (h). 
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Figure 8. Geometry of asymmetric brain-probe system. (A) overall (B) 
cutaway.  The probe has an overall diameter of 500 µm and height of 3 
mm.  The probe is then broken down into the following dimensions: (a) 
50 µm, (b) 75 µm (c) 85 µm (d) 40 µm (e) 50 µm (f) 3 mm (g) 25 µm (h) 
50 µm.  The bore holes near the base of the probe have a diameter of 
60 µm. 
 
 After working with the asymmetric model for some time, discrepancies were 
found that questioned the overall validity of the model.  The largest problem is the fact 
a b c d e 
f 
g 
h 
A B 
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that the cross-sectional area COMSOL was calculating for inlet and outlet boundaries is 
incorrect.  The areas calculated differ significantly from a simple hand calculation (πr2 for 
the inlet and π(ro
2-ri2) for the outlet) based on the same radii. 
 Further unsettling is the fact that the accuracy of this error does not improve with 
a finer mesh.  Apparently, dimensions are not calculated using the mesh; meaning the 
accuracy of dimensions is therefore not dependent on how well the mesh fits the 
geometry.  The dimensions are therefore calculated incorrectly by COMSOL at some 
fundamental computing level.  In fact, even when a simple two-dimensional ring is 
examined in a separate model, the calculated area is different from both the asymmetric 
model and a hand calculation.  This problem led me to question the accuracy of all other 
geometry based results, which includes outlet glucose concentration. 
 In addition to inaccurate geometric dimensions, the asymmetric model is 
inconvenient to work with.  With almost 520,000 elements in the mesh, it takes nearly 10 
minutes to solve it at steady-state and over 7 hours to solve it with the transient model.  
Due to the lack of confidence in the asymmetric model and the inconvenience of running 
it, a more robust means for describing and modeling the brain-probe system was sought 
after. 
 
5.1.2 Axisymmetric Model 
 
 Initially, the three-dimensional asymmetric model was chosen over a radially 
symmetric one because it was believed that the two bore holes at the base of the probe 
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would cause an irregularity in the flow pattern of the active region, leading to a non-
negligible amount of angular diffusion.  However, the use of an axisymmetric model 
(Figure 9) was investigated after the geometric errors were found in the asymmetric 
model.  By assuming that there is no significant angular diffusion, the two bore holes, and 
therefore the entire inlet channel, can be eliminated.  To simplify things further, the inlet 
for the perfusate was chosen to be the bottom boundary of the active region.  With these 
changes, the brain-probe system is still primarily the same; there is the outlet perfusate 
channel (a), membrane (b) and brain layer (c).  There is also still a stainless steel gap (e) 
between the active region of the probe (d) and the bottom layer of the brain (f).  All 
symmetric models, unless otherwise stated, have identical dimensions to the overall 
model and will therefore not be included in every figure. 
 
NOTE: All further figures of probes have been rotated 90° 
counterclockwise; the top of the probe is to the left. 
 
Figure 9. Geometry of the two-dimensional, axisymmetric brain-probe 
system.  The probe has an overall radius of 250 µm and height of 3 mm.  
The probe is then broken down into the following dimensions: (a) 85 µm, 
(b) 40 µm (c) 50 µm (d) 3 mm (e) 25 µm (f) 50 µm.  The perfusate enters 
the model at the base of the outlet flow region. 
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 Testing of the validity of the new symmetric model was based on mass 
conservation and fluid flow.  A mass balance was conducted on each individual domain 
and on the system as a whole.  Overall, the system gains only 4.2 pmol/min of mass, 
which is less than half of the mass gain in the asymmetric model.  The full mass balance 
can be found in Appendix B.  The velocity profile in the perfusate region of the 
symmetric model was also examined to make sure that the skewed parabolic shape 
typical to annuli was conserved.   
 These factors show that, at the same parameters, angular diffusion at the base of 
the probe is negligible and that a simplified, symmetric model can produce accurate 
results.  In addition to a higher level of confidence, the symmetric model is easy to work 
with.  With only 8,000 elements in the mesh, the model can be solved at steady-state in 
less than 10 seconds. 
 Detailed instructions for constructing the two-dimensional steady-state brain-
probe system in COMSOL can be found in Appendix C.  While Appendix C is written 
for people with no COMSOL experience, Appendix D holds a less thorough set of 
instructions for people familiar with COMSOL.  Appendix E has instructions for creating 
a probe geometry that is completely adaptable to any size probe with similar design to the 
CMA 12. 
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5.1.3 Presentation of Results 
 
 COMSOL is able to output results in a variety of different ways.  The two that 
will be used in this project are two-dimensional renderings and line averages.  Figures 10 
and 11 are two-dimensional cutaways of results for the velocity and concentration profile, 
respectively, using the parameters in Table 1.  Note that after solving the two-
dimensional model, COMSOL wraps the results around the central axis to produce a 
three-dimensional geometry with no angular diffusion. 
 
Figure 10. Typical velocity profile of perfusate throughout probe using 
parameters in Table 1.  Units are in m/s. 
 
 
Figure 11. Typical concentration gradient throughout brain-probe system 
using parameters from Table 1.  Units are in mM. 
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 Another useful post-processing computation COMSOL can be used to conduct is 
a line average.  By integrating over the outlet perfusate boundary and dividing by the 
length of the boundary, COMSOL can be used to calculate the concentration of glucose 
leaving the probe in mM. 
 
5.2 Mesh 
 
 An extremely useful feature in COMSOL is the physics-controlled mesh 
sequence.  The parameters chosen by this function are based on hundreds of models 
previously constructed in COMSOL that have similar geometries and physics packages.  
For this simple model, the physics-controlled mesh is able to create a mesh that supplies 
accurate results. 
 Within the physics-controlled system, a pre-defined mesh size that ranges from 
extremely fine to extremely coarse can be chosen.  To determine which size mesh 
minimizes solve time while still providing an accurate solution, an iterative process was 
used.  The model was first solved with the smallest possible mesh; the outlet glucose 
concentration provided by this solution was deemed the “true value”.  The model was 
then solved with an increasingly larger mesh size until the results produced were no 
longer within a 95% confidence range of the true value.   
 For this model, COMSOL chose to construct the mesh using triangular elements.  
Interestingly, all of the mesh sizes were within 99.9% of the “true value”.  All of the 
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concentration results in mM were identical out to the third decimal place.  For this 
reason, the mesh size was based on solve time, which ranged from 101s (extremely fine) 
to 3s (extremely coarse).  The mesh size of “Finer” (10s) was chosen because it had one 
of the highest ratios for number of elements to solve time. 
 
5.3 Sensitivity Analysis 
 
 A sensitivity analysis was conducted on each of the COMSOL model constants to 
determine the parameters to which results are most sensitive.  Each input variable was 
independently tested at 13 different values over a range of 10% to 1000% of the normal 
value.  As the only experimentally measured system output, the probe outlet 
concentration of glucose was used as the dependent variable.   This concentration was 
recorded for each test and graphed against parameter values to determine the sensitivity 
of this key result to each parameter.  As an example, the sensitivity data for perfusate 
volumetric flow rate can be found in Table 2. 
  
34 
 
 
 
Table 2. Raw data for glucose concentration sensitivity analysis of 
perfusate volumetric flow rate (holding all other parameters constant). 
Volumetric Flow Rate 
(m3/s) x1011 
% of Value 
from Normal 
Outlet Glucose 
Concentration 
(mM) 
% of Outlet 
Concentration 
from nominal 
0.17 10 1.196 175.3 
0.84 50 0.819 120.1 
1.12 67 0.755 110.6 
1.52 91 0.698 102.2 
1.59 95 0.691 101.2 
1.65 99 0.684 100.2 
1.67 100 0.683 100.0 
1.69 101 0.681 99.8 
1.75 105 0.675 98.9 
1.84 110 0.668 97.9 
2.51 150 0.628 92.0 
3.34 200 0.598 87.6 
16.70 1000 0.522 76.4 
 
 Appendix F shows results for each of the analyses, while Figure 12 summarizes 
the key results.  In order to validate ZNF assumptions, the COMSOL model must mimic 
the experimental system as closely as possible.  As can be seen in Figure 12, outlet 
glucose concentration is most sensitive to volumetric flow rate.  If volumetric flow rate is 
off by an order of magnitude, the concentration results can be off by as much as 75%, or 
0.51 mM.  Later this fact will be proven as an advantage.  Figure 12 also shows that 
within an order of magnitude, perfusate density and viscosity have no significant effect 
on outlet glucose concentration. 
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Figure 12. Sensitivity analysis.  The orange boxes represent 1000% of the 
system parameter while the blue boxes represent 10% of the system 
parameter.  Outlet glucose concentrations are unaffected by order of 
magnitude shifts in perfusate density or viscosity.  The system parameters 
are: volumetric flow rate (V), brain width (wB), diffusion coefficient of 
glucose in the brain (DB), the membrane (DM) and the perfusate (DP), 
perfusate density (rhoP), and perfusate viscosity (etaP). 
 
5.4 Temperature 
 
 One potential complication is the formation of a temperature gradient within the 
active region of the microdialysis probe.  If a temperature gradient is present, the 
perfusate and membrane properties would vary throughout the probe.  If this is the case, a 
-40
-20
0
20
40
60
80
100
V wB DB DM DP rhoP etaP
De
vi
at
io
n 
in
 O
ut
le
t G
lu
co
se
 
Co
nc
en
tr
at
io
n 
(%
)
System Parameter
36 
 
 
 
thermal package would have to be added to the model and the thermal characteristics for 
each parameter would have to been found. 
 In order to determine if a thermal solver is necessary, a new three-dimensional 
model, which represented the lower 14 mm of the probe, was created in COMSOL. A 
three-dimensional model was chosen over a two-dimensional axisymmetric model.  
Because there is only fluid flow and no diffusion or transport of mass across boundaries, 
the problems associated with the above three-dimensional model were not seen.  Figure 
13 shows the lower 6 mm of this model; the rest of the model is identical to the top (left) 
most section.  It is assumed that the probe is implanted 5 mm into the head of the rat.  
Therefore, in addition to the 3 mm of active membrane that is in the rat head, there is a 
2 mm section of non-active probe also in the head.  The remaining 9 mm of the modeled 
probe is outside of the head and exposed to ambient conditions. 
 
 
Figure 13. COMSOL model used to evaluate presence of a temperature 
gradient.  Units are in µm. 
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 The model is broken up into three sections to represent these three distinct 
temperature regions: the active region of the probe in the head, the non-active section in 
the rat head, and the non-active region that is not in the head.  The geometry of the 
bottom section is identical to the three-dimensional version of the glucose model, except 
without the brain section.  The upper two sections are a simple extension of the 
concentric design, the membrane being replaced with a stainless steel casing.  In each 
section, the relevant boundary condition is the temperature of the environment.  The outer 
surface of the membrane or stainless steel casing is therefore set to a constant temperature 
appropriate for that section.  Because the brain is the source of heat, the domain itself did 
not have to be modeled and was simulated by putting the thermal boundary condition on 
the outer wall of the membrane.  The lower two sections, which are in the head, have a 
boundary condition of 38.2°C, the average temperature of a rat brain.37
 The COMSOL model was run at steady-state using creeping flow and thermal 
physics packages.  The transport of glucose was not modeled because it is irrelevant to 
the thermal profile.  All other parameters are identical to the ones used in the 
concentration model (
  The upper 9 mm 
of the probe has a boundary condition of 23°C, room temperature.   
Table 1).  Results for the entire probe are shown in Figure 14. 
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Figure 14. Temperature profile throughout lower 14 mm of microdialysis 
probe.  Units are in K. The first (right) 3 mm are the active region of the 
membrane. 
 
 To get to the active region, the perfusate has to travel through the connecting 
tubes at the base of the probe.  Figure 14 shows that by the time the perfusate reaches 
these connecting channels, the perfusate has reached complete thermal equilibrium with 
the brain and there is no temperature gradient in the active region of the perfusate flow. 
 To emphasize this fact, Figure 15 shows the temperature profile along the inner 
wall of the outer cannula from the base of the probe, including the section below the 
connecting tubes.  As can be seen, when the perfusate leaves the active region, the 
temperature at the inner wall (the surface furthest from the boundary condition) is 
38.0°C, which is within 99% of steady-state.  With such a minute variation in 
temperature along the active region of the probe, it is a valid assumption to say that 
temperature is constant. 
 
Active Region 
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Figure 15. Temperature profile for the annulus of the probe.  The first (left) 3 mm are the 
active region of the membrane.  The head, and therefore heat source, ends at 5 mm.  The 
remaining 9 mm is open to ambient conditions. 
 
5.5 Zero Net Flux 
 
5.5.1 Validity of Model 
 
To confirm that this model accurately describes in vivo experiments, it was run at 
steady-state using the set of parameters in Table 1 that describes the experimental system 
run at SUNY Albany.5  As can be seen in Figure 16, the model accurately recreates the 
experimentally-determined point of ZNF, and the model’s predicted data describes the 
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slope of the data well with an r2 of 0.90.  The line of best fit for the data only has an r2 of 
0.91. 
 
Figure 16. Comparison of experimental data (♦) with model results 
(orange).  No fitting parameter is used.5 
 
 Importantly, all model parameters were based either on experimentally set 
parameters (flow rate, inlet concentration) or literature (diffusion coefficients, viscosity, 
density), using no “fitting” parameters to adjust the model.  It can therefore be concluded 
that the evidence supports this model as an accurate representation of the brain-probe 
microdialysis system.  Because this model was run at steady-state, the fact that the model 
fits the experimental data shows that assumptions made in using ZNF to analyze 
microdialysis data from this experiment are valid. 
 
-0.25
-0.20
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.15
0.20
0.25
0 0.5 1 1.5 2 2.5
N
et
 C
ha
ng
e 
in
 C
on
ce
nt
ra
tio
n 
(m
M
)
Inlet Glucose Concentration (mM)
41 
 
 
 
5.5.2 Implications of ZNF 
 
In practice, in vivo experiments generate ZNF for an experimental condition and 
then use the slope to relate outlet concentrations. This is possible due to the fact that the 
slope of the ZNF line is dependent only on the volumetric flow rate and the three 
diffusivities.  The slope is not dependent on the brain concentration or on which inlet 
glucose concentration is chosen.  Figure 17 is the result of changing the brain glucose 
concentration from 1.25 mM to 1 mM while keeping all other parameters the same.  This 
shows that the diffusivities of a given brain-probe system can be characterized with one 
number, the slope of the ZNF plot.  The perfusate diffusivity will remain constant as long 
as the same aECF is used. The membrane diffusivity will not change as long as the same 
membrane material is used.  Brain diffusivities are relatively constant throughout a 
species, but may change with age and disease.4  
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Figure 17. ZNF plot (using model data) for the same specimen at a brain 
concentration of 1.25 mM (orange) and after a concentration drop of 0.25 
mM to 1.00 mM (blue). 
 
 Applying the concept in Figure 17 to the fact that the ZNF slope from one brain 
can be applied throughout a set of similar rats can be extremely useful.  By realizing that 
when the brain concentration changes, the ZNF plot simply “shifts” to accommodate a 
new x-intercept, an equation can be crafted  
 cB = cin - 
cout - cin
slope
 (9) 
to quickly calculate brain concentration.  To solve this equation only one set of 
input/output concentrations is needed, once the ZNF slope is known for the specific 
species.  This means effectively, statistics aside, that brain glucose concentrations can be 
known with only one measurement. 
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5.5.3 Time to Steady-State 
 
 The goal of the second hypothesis was to determine the shortest brain activity, i.e. 
a thought, that microdialysis can measure and the limiting factor of the temporal 
resolution.  The three factors that could be limiting are sample size, time to steady-state 
within the probe, and dispersion in the exit tubing. 
 The simplest factor to describe is sample size.  One common means for measuring 
outlet glucose concentrations is taking an aliquot of the dialysate and running an off-line 
fluorometric analysis.  Depending on the sensitivity of the analytical instrument, the 
concentration of the analyte in the dialysate and the flow rate of the perfusate, it usually 
takes 5 to 10 minutes to collect one sample.  The best possible temporal resolution is 
therefore the size (divided by the flow rate) of the sample.  For any further calculations, it 
will be assumed that outlet perfusate is collected for 5 minutes to form a large enough 
aliquot needed for analysis.4  
 To determine the effect of the probe on temporal resolution, a transient COMSOL 
model was created to determine how long the brain-probe system takes to reach steady-
state, both at startup and in response to a thought.  The model is identical to the one in 
Figure 9 except it was run as a transient model instead of at steady-state.  The system 
simulated is initially at rest (no flow) and at 250 s, the rat has a 250 s thought.  The model 
was run out to 750 s and the thought consumed 0.25 mM, making the brain glucose 
concentration 1.00 mM.  Appendix G details instructions for constructing a transient 
model. 
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Figure 18. Transient response of brain-probe system to a 0.25 mM drop in 
brain concentration (black) with an inlet glucose concentration of: 1.0 mM 
(orange), 0.75 mM (blue), 0.5 mM (red), and 0.25 mM (green). 
NOTE: The 15 s delay between the input step and the outlet slope is due to 
the time it takes the fluid to travel through the probe. 
 
 An interesting note is that the decrease in outlet glucose concentration when 
steady-state is re-achieved is independent of perfusate concentration.  In the case of 
Figure 18, the drop in brain glucose concentration was 0.061 mM for all perfusate 
concentrations.  This phenomenon can be attributed to the idea of a constant slope 
presented with Figure 17. 
 Table 3 shows that the closer inlet concentration is to the brain concentration, the 
quicker the system reaches steady-state.  Therefore, the use of a perfusate with a 
concentration close to that of the brain will improve temporal resolution.  But even 
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
0 100 200 300 400 500 600 700 800
O
ut
le
t G
lu
co
se
 C
on
ce
nt
ra
tio
n 
(m
M
)
Time (s)
45 
 
 
 
perfusate with a concentration significantly different from that of the brain still results in 
temporal resolution on the order of 1-2 minutes at the outlet of the probe. 
 
Table 3. Time it takes system to reach steady-state after a 0.25 mM drop 
in brain concentration at several levels of precision. 
Proximity to 
Steady-State (%) 
Time to steady-state (s) 
Cin = 0.25 mM Cin = 1.00 mM 
110 18 0 
101 47 32 
100.1 71 40 
100.01 95 65 
100.001 119 89 
 
Currently, researchers are waiting 20 minutes after startup to begin taking 
samples.  Table 4 shows that the time to steady-state for startup is similar to the reaction 
time to a thought.  However, waiting longer than 2 minutes to start sampling is still 
advisable in case there are any unforeseen changes caused at startup. 
 
Table 4. Time it takes system to reach steady-state from start up at several 
levels of precision (cin=0. 25 mM). 
Proximity to  
Steady-State (%) 
Time to steady-state  
(s) 
90 21 
99 43 
99.9 67 
99.99 90 
99.999 113 
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 Consequently, it can be seen that the brain-probe system will regain steady-state 
within 1-2 minutes after any reasonable perturbation. The time for which the output is at 
the actual thought concentration has shrunk by one minute.  So far, if the analytical 
device requires 5 minutes of gathering for an aliquot and system parameters are similar to 
those used in the transient model, no brain process lasting less than 6 minutes will be 
measurable.  The effect of Taylor dispersion on temporal resolution will be discussed 
later. 
 
5.6 Reverse Microdialysis 
 
 Another reason to accurately model microdialysis is to help develop its use as not 
only an analytic device, but also as a drug delivery unit.  An interesting feature of the 
microdialysis probe is that because transport across the membrane is controlled by a 
concentration gradient, a perfusate can be designed so that the probe runs in “reverse”.  
That is, if the concentration of an analyte is higher in the perfusate than in the brain, the 
analyte will be transported through the membrane and into the brain.  This method of 
drug delivery could have far-ranging implications, especially for delivering drugs that are 
too large to pass through the blood-brain barrier (the dense lining around capillaries).38
 Reverse microdialysis can be seen in 
 
Figure 16; the experimental points to the 
right of the x-intercept have an inlet concentration greater than the brain concentration; 
therefore, they have a negative net change in glucose concentration, meaning glucose was 
lost to the brain. 
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 When modeling ZNF, perfusate concentrations were relatively similar to those in 
the brain; the maximum deviation was 0.75 mM.  Drug delivery deals with adding a 
component at a significant concentration that is otherwise absent from the brain.20,39
Figure 19
  The 
drug can be delivered either highly concentrated over a short period of time as a pulse or 
at a lower, constant concentration.  It has been shown that the ZNF model works well at 
concentrations near the brain.  However, it is a possibility at extreme concentrations, the 
assumptions made in the boundary conditions and homogenization of the brain could 
break down and provide useless data.  For this reason, a separate model was created 
( ) which is identical to the first model except that the brain section is enlarged. 
 
 
Figure 19. Model geometry for reverse microdialysis.  The probe itself 
still has an overall radius of 250 µm and height of 3 mm.  The probe is 
then broken down into the following dimensions: (a) 85 µm, (b) 40 µm (c) 
50 µm (d) 150 µm (e) 3 mm (f) 25 µm (g) 150 µm.  The perfusate enters 
the model at the base of the outlet flow region. 
 
 In the ZNF model, it was assumed that the brain tissue on opposite side of 
capillaries from the probe would not be affected by the transport of glucose to the probe 
because the capillaries are the source of the glucose.  Drugs that are delivered using 
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microdialysis will most likely be too large to pass through the blood-brain barrier (BBB) 
and will therefore not be affected by the capillary.  For this reason, the brain section 
needed to be extended to determine the transport of the drug throughout the entire brain.  
It turns out that beyond 200 µm from the probe, changes in concentration are negligible.  
Anything past 200 µm can effectively be viewed as “infinity” from the probe.  In doing 
this, it is assumed that the capillary does not play a significant role in this process, 
specifically that the response time of the capillary to changes in brain drug concentration 
is much slower than action of the probe. 
 To ensure the model is as robust as possible, it was tested at extreme conditions.  
The system modeled is that of glucose delivered in a pulse to the brain.  This could be 
used for patients severely lacking glucose and in need of fast relief.  The initial 
concentration for glucose in the immediate region of the brain (50 µm) was set to 0.5 
mM, while the outer reaches of the brain (150-200 µm) are set to the normal 1.25 mM.  
At t=1s, the inlet perfusate concentration was changed to 100 mM for a duration of 5s, at 
which point the concentration was held constant at 1.25 mM.  All other parameters are 
unchanged from the ZNF simulation (Table 1). 
 Figure 20 shows the concentration of glucose 50 µm from the probe over time.  
As can be seen by the insert, the depleted region is at first serviced by the non-depleted 
brain immediately adjacent to the depleted region.  However, after a short period, the 
overwhelming amount of glucose from the probe takes over and the concentration sharply 
increases. 
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Figure 20. Brain glucose concentration 50 μm from the probe  when probe 
is perfused with a 100 mM glucose spike for 5 seconds.  Brain starts at 
0.5 mM and perfusate is reduced to 1.25mM at 6 seconds.  The inset is a 
close-up of the first 15 seconds of the simulation. 
 
 These results show that COMSOL and FEM can be used successfully to model 
reverse microdialysis.
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6 Impact of Tubing on Temporal Resolution 
 
 It is important to determine how long a signal has to last in order to get a reading 
unaffected by Taylor dispersion.  As stated in the Background, it was believed that the 
length of the exit tubing causes significant signal dilution and therefore limits the 
temporal resolution of results.  The derivation that follows is an adaptation of G.I. 
Taylor’s original work.40
 
  Before the dispersion process is derived, the basic principles of 
Taylor dispersion will be discussed. 
6.1 Taylor Dispersion 
 
 Dispersion is the axial mixing of a fluid due to the coupling of diffusion and a 
radial velocity gradient.  In a pipe, fluids in the center travel faster than near the walls, 
where velocity is zero due to no slip. One way to visualize this is by looking at the 
transport of a pulse, as in Figure 21.  Due to no slip at the wall and no stress at the center, 
a parabolic flow profile is formed.  If a cross-section of the tube is examined at the front 
of the parabolic profile, the concentration at the center is higher than at the walls.  This 
radial concentration gradient will cause the solute to diffuse from the center radially 
outward towards the less concentrated, slower moving fluid.  Additionally, fluid at the 
rear of the pulse is more concentrated at the walls, because the solute is moving slower.  
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This will cause solute in the rear to diffuse inward to the faster flowing fluid.  The final 
result of this phenomenon is that the signal will spread out as it travels along the tube.  
Taylor dispersion is therefore the axial spreading of solute caused by a radial velocity 
gradient. 
 
 
Figure 21. Example model of Taylor Dispersion, for a pulse.41
 
 
 The system being examined (Figure 22) is a simple one.  It is essentially fully 
laminar flow in a horizontal pipe.  As described in the Background, Stoke’s flow is a 
simplified form of Navier-Stokes, which accurately describes laminar flow.  Therefore, 
even though the flow in the tube is technically considered creep flow, deriving Taylor 
dispersion as laminar flow will still provide accurate results.   
 
Figure 22. Diagram of system to be examined.  Diagram is not to scale. 
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r 
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6.2 Velocity Profile 
 
 When the equations of continuity and motion are adapted to this system 
 vz = −
dp
dz
R2
4μ
�1 − r2
R2
� (10) 
is derived which represent the parabolic flow profile.  In developing Equation 10, it was 
assumed that: density, temperature, and material properties are constant, the system is at 
steady-state, the velocity vector is only dependent on the radial (r) coordinate but only 
non-zero in the axial (z) direction, no body forces exist, no slip at the walls, and no end 
effects.  No end effect is a valid assumption because the length of the tube is so long 
compared to the length of the end effect zone. 
 Boundary conditions used to develop the flow profile are  
 BC1: vz(r = R) = 0;            BC2:  dvzdr  �r=0 = 0. (11) 
 In future derivation steps, it will be helpful to note that  
 vz,max =  vz|r=0 =  − dpdz R24μ            ∴vz = vz,max �1 - r2R2� (12) 
and that 
 〈vz〉 = 
2
R2
∫ vz(r) rdrR0  = - dpdz R28μ �1 - r2R2�  =  12vz,max. (13) 
Therefore 
 vz =2〈vz〉 �1 - r2R2� (14) 
where vz is mass average velocity and 〈vz〉 is the average velocity at a cross section of 
tubing.  vz,max is found at the center of the tubing where there is no stress. 
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6.3 Concentration Profile 
 
 Once the velocity profile was described, the species equation of continuity was 
adapted to the system and resulted in 
 ∂cA
∂t
 + vz ∂cA∂z  = DA �1r ∂∂r �r ∂cA∂r �  + ∂2cA∂z2 � (15) 
where cA is the concentration of glucose in the fluid and DA is the coefficient of diffusion 
for glucose in aECF. 
 In addition to the using the same geometric assumptions stated in the Velocity 
Profile section, it was additionally assumed that there is no reaction, that concentration is 
independent of angle (dependent solely on the r and z coordinates), and that the diffusion 
coefficient is constant. 
 The boundary conditions for Equation 15 are  
 BC3: cA(t, r = 0, z) is bounded;            BC4: ∫ ∫ cA′ r ∂r ∂φ102π0 . (16) 
where φ is the angular coordinate and ca’ is a variable that will be explained below. 
 For this case, in which an approximation for long times are desired, it is sensible 
to use a coordinate system that translates with the average velocity.  This new traveling 
variable, δ, is 
 δ ≡ z -〈vz〉t (17) 
in which the derivative of is 
 D
Dt
≡  ∂
∂t
+  〈vz〉 ∂∂z. (18) 
Applied to the concentration and solved for ∂/∂t 
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 ∂cA
∂t
=  DcA
Dt
− 〈vz〉 ∂cA∂z  (19) 
 Using Equation 19 and applying it to Equation 15 along with the axially shifted 
coordinate in Equation 17 produces 
 DcA
Dt
+  vz′ ∂cA∂δ = DA �1r ∂∂r �r ∂cA∂r � +  ∂2cA∂δ2 � (20) 
where 
 vz′  ≡ (vz −  〈vz〉)  =  〈vz〉 �1 − 2 r2R2�. (21) 
is the deviation velocity. 
 Equation 20 is then nondimensionalized using 
 θ =  cA cA,ref� ;         η = r R� ;            ξ = z L� ;          γ =  〈vz〉t L�         (22) 
where θ, η, ξ, and γ are the dimensionless concentration, radial, axial, and time variables, 
respectively.  cA,ref is an arbitrary reference concentration.  The specific value of cA,ref is 
not needed because it will not be present in the solution.  All variables are designed so 
that the entire domain is scaled to range between 0 and 1. 
 The result of nondemensionalizing and rearranging Equation 20 is 
 Pe R
L
�
Dθ
Dγ
+  v ∂θ
∂δ
�  = 1
η
∂
∂η
�η
∂θ
∂η
� + �R
L
�
2 ∂2θ
∂δ2
 (23) 
where 
 v ≡  v′z 〈vz〉� =  �1 − 2 r2R2� =  (1 − 2η2) (24) 
and 
 Pe =  〈vz〉R
DA
. (25) 
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The Péclet number, Pe, is a dimensionless variable that relates axial convection to radial 
diffusion.  Taylor assumed that in systems where dispersion is prevalent, Pe » 1; 
convection is much faster than diffusion.  The Pe number for this system is 60, which is 
large enough for Taylor dispersion.42
 A decomposition of the concentration is then proposed so that 
 
 θ (η, ξ, γ) =  〈θ〉 (ξ, γ) +  θ′(η, ξ, γ) (26) 
where 〈𝜃〉 is the cross-sectional average of θ which is independent of r.  θ’ is the 
difference between the average concentration and the actual concentration at any point.  
Generally, the decomposition is made with the expectation that 〈θ〉 » θ’. 
 Applying this decomposition to Equation 23 results in 
 Pe R
L
�
D〈θ〉
Dγ
+ Dθ′
Dγ
+ v �∂〈θ〉
∂δ
+  ∂θ′
∂δ
��  = 1
η
∂
∂η
�η
∂θ
∂η
� +  �R
L
�
2
�
∂2〈θ〉
∂δ2
+ ∂2θ′
∂δ2
� (27) 
where use was made of the fact that 〈𝜃〉 is independent of η. 
 The next step is to take the cross-sectional average of Equation 24 in order to 
obtain an equation for 〈𝜃〉.  First however, it is useful to note that two properties of the 
decomposition in Equation 26 are 
 〈〈θ〉〉 =  〈θ〉        and      〈θ′〉 = 0. (28) 
 The cross-sectional average of Equation 27 is 
 Pe R
L
�
D〈θ〉
Dγ
+ 〈v ∂θ′
∂δ
〉�  = �R
L
�
2
�
∂2〈θ〉
∂δ2
�. (29) 
Because this derivation is interested in dispersion at long times, or long tubing, L » R.  
This means that the final term in Equation 29 can be considered negligible compared to 
the other terms, resulting in 
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 D〈θ〉
Dγ
 = - 〈v ∂θ′
∂δ
〉 (30) 
which shows that Taylor dispersion is due to the averaged product of deviations from the 
mean velocity and concentration.  To solve Equation 30 for 〈𝜃〉, θ’ needs to be defined.  
To generate an equation for θ’, subtract Equation 29 from Equation 27 to produce 
 Pe R
L
�
Dθ′
Dγ
+ v �∂〈θ〉
∂δ
+  ∂θ′
∂δ
��  =  Pe R
L
〈v ∂θ′
∂δ
〉 + 1
η
∂
∂η
�η
∂θ′
∂η
� + �R
L
�
2 ∂2θ′
∂δ2
. (31) 
 This equation cannot be solved analytically and must be approximated by 
neglecting terms based on relative magnitudes.  Again, because L » R, the third term on 
the right-hand side of Equation 31can be neglected.  It can further be assumed that 
L » PeR, therefore allowing the first term on the right-hand side to be neglected.  This 
leaves the radial diffusion term as the predominant term on the right-hand side of 
Equation 31. 
 Even though it is assumed that L » PeR, at least one term on the left-hand side of 
Equation 31 needs to be significant in order to balance out the remaining term on the 
right-hand side.  Taylor assumed that 〈𝜃〉 » θ’, which leaves the average axial convection 
term as the dominant term on the left-hand side Equation 31.  These approximations 
reduce Equation 31 to 
 Pe R
L
v ∂〈θ〉
∂δ
 =  1
η
∂
∂η
�η
∂θ′
∂η
�. (32) 
 Equation 32 can be solved for θ’ by integrating twice with respect to η and 
applying the boundary conditions in Equation  16.  The result is 
 θ′ = PeR
L
∂〈θ〉
∂δ
�
η2
4
+ η4
8
+ 1
12
�, (33) 
which when used in Equation 30 produces 
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 D〈θ〉
Dγ
 = 〈vz〉R
2
48DAL
∂2〈θ〉
∂δ2
. (34) 
When this equation is dimensionalized and the axially shifted coordinate system is 
removed 
 𝜕〈𝑐𝐴〉
𝜕𝑡
+ 〈𝑣𝑧〉 𝜕〈𝑐𝐴〉𝜕𝑧 = 𝐾 𝜕2〈𝑐𝐴〉𝜕𝑧2  (35) 
where  
 K =  R2〈vz〉2
48DA
. (36) 
 K is defined as the Taylor dispersion coefficient and has the same units as a 
diffusion coefficient.  This fact shows that dispersion, while truly a combination of the 
parabolic velocity profile and radial diffusion, has the appearance of axial diffusion.  
 The next step is to get an explicit equation for 〈𝑐𝐴〉.  Equation 35 is a second order 
PDE with 〈𝑐𝐴〉 as the only dependent variable.  The equation can easily be solved using a 
Fourier transform.  The result of this transform is 
 ∂CA
∂t
 + 〈𝑣𝑧〉i2πh𝐶A = K(i2πh)2𝐶𝐴 (37) 
a first order ODE where h is the independent variable in Fourier space and CA is the 
Fourier concentration.  Solving for CA 
 CA=G(h) e(K(i2πh)2-〈vz〉i2πh)t (38) 
where G(h) is the signal function, or the form of the original input function.  By taking 
the inverse Fourier, g(z) is convolved with the inverse of the exponential term  
 〈cA〉(z) = g(z) * 
1
�4K𝑡outπ
e-�
z2
4K𝑡out
� = 1
�4πK𝑡out
∫ g(y)e-��z - y�24K𝑡out�dy∞-∞ . (39) 
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Where tout is the time it takes the fluid to reach the analytical instrument.  Note that the 
second term in the convolution has the form of a normal Gaussian distribution.  The y in 
Equation 39 is a dummy variable used to pass one function over the other and to 
effectively smear them together. 
 Now there is an explicit equation that provides the average concentration profile 
of the solute as a function of axial distance, which is related proportionally to time in 
tubing by the average velocity.  This can be used to determine at what point signals 
become indistinguishable from each other. 
 
6.4 Convolution 
 
 Equation 39 is in the form of a convolution.  Essentially, a convolution takes one 
function and rubs another function over it, causing smearing.  As can be seen in Figure 
23, there is a signal function (A, steps) and a smearing function (B, Gaussian curve).  The 
signal is smeared by the Gaussian curve.  The graph in Figure 23.C is the result.  The 
output still has the same general form as the signal; however, the peaks have started to 
blend together.  If the width of the bell curve in Figure 23.C is increased, the two 
individual peaks will eventually become indistinguishable from each other and no useful 
data will be attainable. 
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Figure 23. Example of Convolution. A) signal, B) smearing function, C) 
result. 
 
6.5 Signal 
 
 For this system, the signal is the concentration profile that enters the exit tubing.  
Shown again in Figure 24 (originally in Figure 18), this profile was approximated by a set 
of Boltzmann sigmoidal equations. 
 
A 
B 
C 
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Figure 24. Plot of actual signal (blue) compared to Boltzmann sigmoidal 
(orange) fit (r2 = 0.9996).  The data is originally found in Figure 18; a 250 
s signal with one minute of dilution due time to steady-state in the probe. 
 
 The Boltzmann sigmoidal  
 cA =  B + T−B
1+e
�
ha−t
m �
 (40) 
where B is the concentration during the signal (minimum), T is the nominal concentration 
(maximum), ha is the time at which the concentration is halfway between B and T, and m 
is the slope of the curve at t = ha, only encompasses one concentration change.  For that 
reason, one sigmoidal models the drop in concentration (100 to 400s), while a second 
function models the concentration increase (400 to 750s).  The first 100s was not 
modeled because the focus is on the impact dispersion has on signals, not startup. 
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 For both the decrease and increase, the equations used are identical except the 
slope (m) is opposite and the half-time (ha) is different.  When compared to the 
COMSOL data, the Boltzmann sigmoidals fit with an r2 of 0.9996.  To fit in with 
Equation 39, the Boltzmann fit has to be shifted from the time domain (t) to the space 
domain (z). This is done by multiplying m, h, and the time domain by the average 
velocity in the tubing. 
 
6.6 Effect of Taylor Dispersion on Concentration Results 
 
 Applying the adjusted Equation 40 to Equation 39 in the context of the relevant 
system (shown in Figure 22 and described in Table 5) and running the convolution 
function produces Figure 25.  1,000 seconds were added to the beginning and end of the 
signal so that the convolution of the ends (which MATLAB treats as a concentration of 0) 
does not affect the actual signal.  The complete MATLAB mfile used for this model can 
be found in Appendix H.  A second mfile was created that shows the state of the signal as 
it travels down the tubing.  This transient version can be found in Appendix I. 
 
Table 5. Physical parameters for exit tubing. 
Variable Expression Value Units 
L Length of tubing 2 m 
V Volumetric flow rate 1.67x10-11 m3/s 
D Diffusion coefficient of glucose in perfusate 8.3x10-10 m2/s 
R Inner radius of tubing 1.075x10-4 m 
rhoP Dialysate density 990 kg/m3 
etaP Dialysate kinematic viscosity 7.28x10-4 Pa s 
K Dispersion coefficient 6.22x10-8 m2/s 
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Figure 25. Convolution results for system.  Times shown are the times it 
takes to get from 99% of the nominal concentration to 101% of the 
concentration during the brain process. 
 
 Figure 25 shows that by the time glucose reaches the detector, the signal 
(originally 250s wide) has dispersed 246 s, leaving only a 4 s duration that is at the true 
brain process concentration.  This degradation includes time to steady-state in the probe 
and dispersion in the exit tubing; 185 s of the total degradation time is due to dispersion.  
Keeping in mind that the analytical instrument requires sampling for a duration of 300 s 
(five minutes), Figure 25 shows that it is impossible for an aliquot to accurately reflect 
the concentration during the brain function.  This idea is easier seen in Figure 26 where 
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the output graph is separated into samples, and the concentrations both at the outlet of the 
probe and at the end of the exit tubing are shown. 
 
Figure 26. Concentrations read by analytical instrument.  The graph is 
broken up by the dashed lines into aliquots gathered for 5 minutes.  The 
numbers at the top (represented on the graph by blue squares) are the 
concentrations the analytical instrument would read if placed at the outlet 
of the probe.  The numbers at the bottom (represented on the graph by red 
squares) are the concentrations the instrument would read when placed at 
the end of 2 m of exit tubing. 
 
 None of the aliquots in Figure 26 provide the true outlet glucose concentration.  
To procure at least one valid sample of the brain function concentration, the brain process 
needs to last at least as long as twice the sampling time, plus the time of dispersion due to 
the probe and the exit tubing.  For example, if the analytical instrument requires five 
minutes of sampling, the probe reaches steady-state in 61 s, and the signal experiences 
0.6826 mM 0.6826 mM 0.6826 mM 0.6826 mM 0.6826 mM 0.6724 mM 0.6420 mM 
0.6826 mM 0.6826 mM 0.6713 mM 0.6432 mM 0.6824 mM 0.6826 mM 0.6826 mM 
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185 s of dispersion, the original signal needs to last longer than 846s (5 min*60 s/min * 2 
samples + 61 s to steady-state + 185s of dispersion).  This concept is shown more 
succinctly by 
 𝑡𝑠𝑖𝑔𝑛𝑎𝑙 > 2 ∗ 𝑡𝑠𝑎𝑚𝑝𝑙𝑒 + 𝑡𝑠𝑡𝑒𝑎𝑑𝑦−𝑠𝑡𝑎𝑡𝑒 + 𝑡𝑑𝑖𝑠𝑝𝑒𝑟𝑠𝑖𝑜𝑛. (41)  
 Equation 41 can divided through by tsignal to form a dimensionless group, the 
Vinciguerra number 
 Vi = 2∗tsample+tsteady−state+tdispersion
tsignal
 (42) 
where 
 2 ∗ tsample  =  2mminV̇⌊c⌋MW, (43) 
 𝑡𝑠𝑡𝑒𝑎𝑑𝑦−𝑠𝑡𝑎𝑡𝑒 =  0.85
√vz
+ 7000Lp + 5x10−5�Dlim − 45, (44) 
and 
 tdispersion = 6.5�KLvz3 − 50. (45)  
is produced to determine if, given a set of experimental parameters, an accurate 
measurement could be seen.  If Vi is less than 1, then one of the aliquots taken, if 
sampled continuously, will contain the true glucose concentration during the brain 
function. 
 The first term in the numerator gives the time it takes to collect two aliquots based 
on the minimum mass limit for the analytical device (mmin), the volumetric flow rate 
through the tubing (V̇), the lowest possible analyte concentration (⌊c⌋), and the molecular 
weight of the analyte (MW).  This term represents the absolute smallest aliquot that could 
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be read by the specified analytical instrument.  If aliquots taken are larger than the 
minimum, this term should be replaced by the collection time for two aliquot (volume of 
aliquot / volumetric flow rate of perfusate). 
 The second term in the numerator is an approximation for the amount of signal 
degradation due to time to steady-state in the probe.  The coefficients for this term were 
fit from an extensive set of data which can be found in Appendix J.  This correlation is 
based on the velocity of the perfusate in the outlet flow region (vz), the length of the 
active region of the probe (Lp), and the limiting diffusion coefficient (Dlim).  Note that the 
coefficients in this term are dimensional and therefore, units for velocity, length and 
diffusivity have to be in m/s, m and m2/s, respectively.  The term will provide an 
approximation for time to steady-state accurate to within an order of magnitude for 
steady-state times greater than 30s 
 The final term in the numerator approximates the amount of signal degradation 
due to Taylor dispersion in the exit tubing.  Again, the coefficients for this term were fit 
from a set of data found in Appendix J.  This approximation is based on the dispersion 
coefficient (K), the length of the exit tubing (L), and the average velocity through the 
tubing (vz).  This term is accurate to within 5% for any dispersion times greater than 40 s 
and within 10% for times greater than 30 s. 
 No other dimensionless groups that relate signal length to analytical sensitivity 
and dispersion are apparent in literature.  Figure 27 shows a brain process lasting 846 s 
and the associated dispersion given the same parameters used in Figure 26.  The Vi 
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number for this case is 1, meaning that at least one of the aliquots reflects the true outlet 
glucose concentration, as seen in Figure 27. 
 
Figure 27. Concentrations read by analytical instrument in the case where 
the Vi number is 1.  The graph is broken up by the dashed lines into 
aliquots gathered for 5 minutes.  The numbers at the top (represented on 
the graph by blue squares) are the concentrations the analytical instrument 
would read if placed at the outlet of the probe.  The numbers at the bottom 
(represented on the graph by red squares) are the concentrations the 
instrument would read when placed at the end of 2 m of exit tubing. 
 While Taylor dispersion in the exit tubing does not have a significant effect on the 
concentration read by the analytical instrument, it does increase the length of the smallest 
measurable thought, by more than 4 minutes in the above case.
0.6826 mM 0.6826 mM 0.6824 mM 0.6422 mM 0.6217 mM 0.6230 mM 0.6720 mM 0.6826 mM 0.6826 mM 
0.6826 mM 0.6826 mM 0.6826 mM 0.6826 mM 0.6826 mM 0.6420 mM 0.6217 mM 0.6217 mM 0.6733 mM 
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7 Discussion 
 
7.1 Validity of model 
 
 It was hypothesized that assumptions made in using zero-net-flux to analyze 
microdialysis data are accurate.  The major assumption tested was that the system is able 
to reach steady-state.  It was also hypothesized that the system takes less than 15 minutes 
to reach steady-state.  By creating a three-dimensional finite element model of the 
system, it was possible to validate all assumptions. 
 In addition to the proof of validity given above (Figure 16 in particular), a mass 
balance on the model is given in Appendix B.  The model has an overall relative mass 
imbalance of 0.60%, an acceptably small error. There are, however, some limitations to 
the usefulness and robustness of the model.  The largest inhibiting factor for this model is 
the assumption made in simplifying the brain.  The boundary condition is constant at the 
nominal brain ECF concentration, regardless of brain activity and external influences.  In 
reality, the source of glucose is the capillaries and the concentration of glucose in the 
blood stream varies in time and is even dependent on brain activity.  However, because I 
am interested solely on ECF glucose concentrations, I am able to eliminate the capillaries 
from the model and replace them with a boundary condition that reflects nominal ECF 
concentration levels. 
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 Another limiting aspect is the fact that the reaction term is built into the effective 
diffusion coefficient.  Coupled with the assumed boundary condition, the effective 
diffusion coefficient is able to accurately describe the tortuous path glucose molecules 
take from capillary to the probe and the consumption of glucose by brain cells.  This 
combination works well with glucose, but could fail for other molecules that do not 
behave similarly.  For instance, molecules that react in the ECF or molecules that do not 
react at all will have to be modeled differently.  For the most part, they should be able to 
be worked into an effective diffusion coefficient, just as glucose is, but the process for 
deriving that coefficient may be different. 
 The model also has a size limitation.  Just as continuum mechanics cannot 
properly describe molecular and atomic interactions, this model cannot describe non-
continuum interactions; this is due to the homogeneous assumption of the brain.  
Fortunately in this aspect, the probe itself is the limiting agent and not the model.  Probes 
can only be manufactured so small, and are therefore limited in their spatial selectivity.  
They cannot, for instance, measure the concentration of neurotransmitters being passed 
between a certain neuron.  As long as microdialysis probes remain in the analytical realm 
of continuum mechanics, this model can provide an accurate description of the system. 
 Even with the three limitations found above, it has been shown that microdialysis 
is an accurate and efficient means for measuring brain ECF concentrations, that ZNF is a 
valid tool for translating microdialysis data into true concentrations, and that the finite 
element model presented here can properly describe a brain-probe system. 
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7.2 Comparison to Literature 
 
 As stated above, theoretical approaches to modeling microdialysis tended to be 
specific and over complicated.21  For this reason, results will only compared to other 
numerical approaches.  Both Norton et al. and Wang et al. modeled an in vitro system 
and found times to steady-state of 20 s and 30 s, respectively.26,27  It makes sense that 
their time to steady-state is shorter because, as Zetterström discovered, glucose diffusion 
in brain tissue is much slower than in aECF.23  If the brain domain is removed and the 
outer boundary of the membrane is set to nominal brain concentration, the probe can 
effectively be modeled as in a well-stirred beaker.  Modeling the probe this way, the time 
to steady-state of 45 s, which is close to results from Norton et al. and Wang et al. 
 While Norton et al. modeled exit tubing dispersion in MATLAB (they also used a 
sigmoidal signal function), Wang et al. quantified the dispersion using experimental 
procedure.  Results presented here for dispersion times are very close to those of Norton 
et al., which helps verify the validity of this approach.  Wang et al. only presented data 
from one trial, and it was in graphical form.  However, when experimental parameters are 
estimated and entered into the MATLAB file, dispersion times are similar.27 
 
7.3 Implications 
 
 Once microdialysis, ZNF, and this model have been established, the next step is 
finding a use for these results.   
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7.3.1 Parameter Sensitivity 
 
 Prior to this model, the only sensitivity data that was available was on the 
analytical instruments.  A detailed description of the effect that experimental parameters 
had on concentration results did not exist.  By modeling the entire system and by being 
able to individually set each of these parameters, it is now possible to determine the 
sensitivity of results to any parameter.  The sensitivity analysis is not limited to one 
parameter; the model allows for changing more than one parameter at a time.  This is 
helpful in designing the experiment.  For instance, from the results above, it is now 
apparent that it is not necessary to find the exact perfusate density; any value within 
reason would produce valid results. 
 
7.3.3 Future Work 
 
 There are many areas of microdialysis still to be explored.  This model will 
hopefully aid in opening up these fields and improving the techniques.  One way to 
improve the robustness of the model would be to un-simplify the brain.  If using 
COMSOL, a homogeneous brain material would still be needed for continuum 
mechanics.  However, a reaction term could be added to the brain domain that would 
describe uptake of glucose into brain cells.  In addition, a capillary complete with a 
blood-brain barrier could be created to replace the concentration boundary condition in 
the symmetric model.  This would allow the blood glucose concentration to be the 
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boundary condition, which is more realistic than the outer wall of the blood-brain barrier 
having a constant concentration. 
 One of the most useful implications for reverse microdialysis is in membrane 
characterization.  By running the probe in vitro, the environmental concentration is no 
longer an unknown because fluid medium can be specifically made.  Because the external 
concentration is no longer an unknown, it is possible to solve for a different variable, i.e. 
the membrane diffusion coefficient..  Experimentally, the probe would first need to be 
run in vitro at a variety of solution and perfusate concentrations, recording the outlet 
concentration each time.  The model can then be easily adapted to in vitro by removing 
the brain domain and setting the outer boundary of the membrane to the solution 
concentration (assuming a well-mixed solution).  Then the model could simply be run at 
varying membrane diffusivities until the modeled outlet concentrations match 
experimental results. 
 The model is useful in many other “what if” scenarios.  For instance, the model 
can be used to determine the highest flow rate possible without draining the brain glucose 
to a critical level.  It is known that as brains get older, the nominal glucose concentration 
remains the same, but glucose diffusion through the brain slows down.  Knowing all 
other data, brain diffusivities can be back-calculated using this model.  The model is 
widely adaptable and simple to operate, and uses for the model will be far reaching. 
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7.4 Taylor Dispersion 
 
 The effects of Taylor dispersion were investigated due to a lack of agreement in 
the literature. One article concluded that dispersion was negligible, while another claimed 
it to be the limiting factor in temporal resolution.26,27  The two papers had consistent 
results but differing perspectives.  Norton et al. was looking at large, long-lasting signals, 
while Wang et al. was trying to precisely describe the short transient period during 
concentration changes. 
 In the case presented here, time to steady-state degrades the signal nearly as much 
as dispersion in the tubing, 60 s to 104 s, respectively.  When working with awake, 
freely-moving rats and long exit tubing is necessary, Taylor dispersion should not be 
ignored. 
 The mfile was run at increasingly shorter tube lengths to determine at what point 
dispersion is negligible.  Even with a tube length of 0.1 m (a customary length for 
anaesthetized rats), the signal is still degraded 12 s by dispersion.  This could be 
considered negligible for large scale brain functions, but as microdialysis techniques 
improve and as researchers want to look at shorter and shorter brain functions, even 
dispersion in short tubes will have to be considered.
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8. Conclusion 
 
 In this thesis, I created a model based on first principles and well-founded 
parameters that accurately describes a real microdialysis system.  With this model, I was 
able to show the validity of ZNF and the accompanying assumptions.  I was also able to 
prove that the ZNF slope is independent of brain concentration, a feature that is helpful in 
practice.  Furthermore, I determined that it takes approximately one minute for the probe 
to reach steady-state after both startup and an environmental change.  The model allowed 
me to determine the sensitivity of results to each individual parameter, values that were 
inaccessible experimentally.  Using a separate model, I was able to show that the 
perfusate is in thermal equilibrium with the brain throughout the active region of the 
probe. 
 I quantified the extent of Taylor dispersion in probe exit tubing.  For a two meter 
tube, a common length for testing awake specimens, the dispersion time is around two 
minutes.  Signal degradation should not be thought of in the typical limiting factor sense 
because the three factors that affect necessary signal time are additive, not competitive.  
The sensitivity of the analytical instrument, the time to steady-state in the probe, and the 
amount of dispersion in the tubing all compound to increase the length of the shortest 
measurable thought.  I designed a dimensionless number to help quantify this concept.  
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 Mass Balance 
 
 
 
Boundary conditions for Stokes Creep Flow (Equation 3). 
Model is not shown to scale. 
 
 
 
 
 
 
 
 
 
BC: Inlet- defined as a 
laminar inflow and set using 
volumetric flow rate 
BC: Outlet 
BC: No slip 
u = 0 
Navier-Stokes 
not solved for in 
these domains 
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 Mass Balance 
 
 
 
Boundary conditions for Conservation of Mass Equation (Equation 4). 
Model is not shown to scale. 
 
BC: Inflow- set as a 
constant concentration, 
defined as the inlet 
glucose concentration 
BC: Outlet 
BC: Concentration- set 
as constant uniform 
concentration, defined 
as average ECF glucose 
concentration 
BC: All other 
external boundaries 
are set as no flux 
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Creating a CMA-12 Brain-Probe System 
 
Open COMSOL 4.2 
From the Model Wizard window, select 2D axisymmetric and press next (light blue 
arrow) 
From the Add Physics tree, select Fluid Flow>Single-Phase Flow>Creeping Flow (spf) 
Click the Add Selected button at the bottom (light blue plus sign) 
From the Add Physics tree, select Chemical Species Transport>Transport of Diluted 
Species (chds) 
Press the Add Selected button, the press next 
From the Studies tree, select Preset Studies for Selected Physics>Stationary 
Press Finish (checkered flag) to start modeling 
 
In the Model Builder window, right-click Global Definitions and choose Parameters 
Go to the Settings window for Parameters 
In the Parameters table, enter the following settings (the name column is case sensitive) 
 
Name Expression Description (optional) 
V 1.67e-11 [m^3/s] Volumetric flow rate, perfusate 
rhoP 990 [kg/m^3] Density, perfusate 
etaP 7.28e-4 [kg/(m*s)] Dynamic viscosity, perfusate 
c0P 0.5 [mol/m^3] Initial concentration, perfusate 
c0B 1.25 [mol/m^3] Initial concentration, brain 
cC 1.25 [mol/m^3] Concentration in sampling fluid 
DP 8.3e-10 [m^2/s] Diffusion coefficient, perfusate 
DM 7.62e-11 [m^2/s] Diffusion coefficient, membrane 
DB 1.16e-10 [m^2/s] Diffusion coefficient, brain 
 
(If you intend to make any more models in the future, it may be beneficial to save your 
parameters as a text file.  You can do this by selecting the Save to file button (looks like a 
floppy disk) located under the parameters table.) 
 
Modeling the System 
From the Model Builder window, select Geometry 1  
In the Settings window for Geometry, change the Length Unit from m to µm 
From the Model Builder window, right-click Geometry 1 and choose Rectangle 
In the Settings window for Rectangle, enter the following dimensions: 
Width: 85  
 Height: 3000 
 Base: Corner 
  r: 125  
  z: 0  
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From the Model Builder window, right-click Geometry 1 and choose Rectangle 
In the Settings window for Rectangle, enter the following dimensions: 
Width: 40  
 Height: 3000 
 Base: Corner 
  r: 210  
  z: 0 
 
 
From the Model Builder window, right-click Geometry 1 and choose Rectangle 
In the Settings window for Rectangle, enter the following dimensions: 
Width: 50  
 Height: 3025 
 Base: Corner 
  r: 250  
  z: -25 
 
From the Model Builder window, right-click Geometry 1 and choose Rectangle 
In the Settings window for Rectangle, enter the following dimensions: 
Width: 300  
 Height: 50 
 Base: Corner 
  r: 0  
  z: -75 
 
From the Model Builder window, right-click Geometry 1 and choose Boolean 
Operation>Union 
In the Graphics window, left-click on the right most rectangle (r3) (the domain should 
turn red) and then right-click the same rectangle (the domain should turn blue and 
is now added to the Input objects list in the Settings window).  Repeat this step 
for r4, the lowest rectangle. 
The Input objects list should now contain: r3 and r4 
Uncheck the Keep interior boundaries box 
 
From the Model Builder window, select Form Union 
In the Settings window for Finalize, select Build Selected (the light blue skyscraper with 
red box, near the top) 
 
In the Model Builder window, minimize the Geometry 1 menu (white downward arrow 
head next to  Geometry 1) 
 
You now have a 2D representation of the brain-probe system that will produce accurate 
results.  The inner (left most) rectangle is the perfusate domain.  Fluid will come in from 
the bottom and exit to top.  The middle rectangle is the membrane.  And the backwards-L-
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shaped domain is the brain.  When solving, COMSOL will “wrap” this 2D section 
around the r=0 axis (red dashed line) to form a 3D cylinder.  We can use the 2D 
axisymmetric model because the system is angle independent.  Now you will assign 
domain and boundary conditions to the geometry. 
 
Perfusate Settings 
 
From the Model Builder window, select Creeping Flow 
In the Settings window, use the control button on your keyboard to simultaneously select 
the following Domains: 1, 3 
Press the Remove from Selection button (light blue minus sign to the right of the 
selection field) 
You may have to scroll the Settings window over to see the button. 
In the Settings window, under Physical Model, change Compressibility to 
Incompressible flow 
 
Expand the Creeping Flow menu by clicking the rightward facing arrow next to 
Creeping Flow 
From the Model Builder window, select Creeping Flow>Fluid Properties 1 
In the Settings window, change Density to User defined and enter “rhoP” into the edit 
field (do not include the quotation marks) 
In the Settings window, change Dynamic viscosity to User defined and enter “etaP” into 
the edit field 
You have just assigned conditions of incompressible creep fluid flow to the probe. We do 
not do this for the other parts of the model because the brain and membrane do not 
contain fluid flow.  The next step is assigning the boundary conditions governing the flow 
of the perfusate.  
 
From the Model Builder window, right-click Creeping Flow and select Inlet 
In the Graphics window, left-click the bottom boundary of r1 (the perfusate domain) and 
then right-click 
In the Settings window, the Boundary Selection list should now contain: 5 
In the Settings window, under Boundary Conditions, change Boundary Condition to 
Laminar inflow 
Under Laminar Inflow, select Flow rate and then enter “V” into the V0 edit field 
Enter “0” into the Lentr edit field and select the box next to Constrain endpoints to zero 
 
From the Model Builder window, right-click Creeping Flow and select Outlet 
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the 
right-click it 
In the Settings window, the Boundary Selection list should now contain: 6 
 
Minimize the Creeping Flow menu 
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Expand the Transport of Diluted Species menu 
 
From the Model Builder window, right-click Convection and Diffusion 1 and select 
Rename 
F2 is the shortcut key for renaming an item. 
Change the name to Perfusate and press OK  
In the Settings window, under Model Inputs, change the Velocity field to Velocity 
Field (spf/fp1) 
In the Settings window, under Diffusion, enter “DP” into the Diffusion coefficient edit 
field 
 
From the Model Builder window, right-click Initial Values 1 and select Rename 
Change the name to Initial Perf/Memb Values and press OK 
In the Settings window, under Initial, enter “c0P” into the Concentration edit field 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Inflow 
In the Graphics window, left-click the bottom boundary of r1 (the perfusate domain) and 
then right-click 
In the Settings window, the Boundary Selection list should now contain: 5 
In the Settings window, under Concentration, enter “c0P” into the c0,c edit field 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Outflow 
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the 
right-click it 
In the Settings window, the Boundary Selection list should now contain: 6 
 
 
Membrane Settings 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Convection and Diffusion 
From the Model Builder window, right-click Convection and Diffusion 2 and select 
Rename 
Change the name to Membrane and press OK 
In the Graphics window, left-click the middle rectangle (r2) and then right-click it 
In the Settings window, the Boundary Selection list should now contain: 3 
In the Settings window, under Diffusion, enter “DM” into the Diffusion coefficient edit 
field  
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Brian Settings 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Convection and Diffusion 
From the Model Builder window, right-click Convection and Diffusion 3 and select 
Rename 
Change the name to Brain and press OK 
In the Graphics window, left-click the backwards-L-shaped domain and then right-click 
it 
In the Settings window, the Boundary Selection list should now contain: 1 
In the Settings window, under Diffusion, enter “DB” into the Diffusion coefficient edit 
field 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Initial Values 
From the Model Builder window, right-click Initial Values 2 and select Rename 
Change the name to Initial Brain Values and press OK 
In the Graphics window, left-click the backwards-L-shaped domain and then right-click 
it 
In the Settings window, the Boundary Selection list should now contain: 1 
In the Settings window, under Initial, enter “c0B” into the Concentration edit field 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Concentration 
In the Graphics window, alternatively left- and right-click the two right most and the 
lowest boundary and then right-click them (the second right most boundary is 
small and at the bottom) 
In the Settings window, the Boundary Selection list should now contain: 2, 13 and 14 
In the Settings window, under Concentration, select the box next to Species c and enter 
“cC” into the c0,c edit field 
 
Minimize the Transport of Diluted Species menu 
 
 
Mesh 
 
Now you have set up all the physics governing the system. Next, a mesh must be created 
which COMSOL will solve the equations over and then solve the problem.  Fortunately, 
COMSOL has suggested meshes for certain physics and geometries.  The suggestion 
works for our case and is the default mesh; so you do not have to do anything. 
 
From the Model Builder window, select Mesh 1 
In the Settings window, make sure the Sequencing type reads Physics-controlled mesh 
and the Element size is Normal 
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Solving 
 
From the Model Builder window, right-click Study 1 and select Parametric Sweep 
In the Settings window, select the Add button (light blue plus sign) 
Select c0P (Initial concentration, perfusate) from the list and press OK 
 
In the Parameter Values edit field, enter the inlet concentrations you are using for the 
ZNF method,  separating each concentration by a space 
 For example, entering: “0.5 1 1.5 2” will tell COMSOL to run the model 4 times 
with each run having one of the following inlet concentrations: 0.5 mM, 1.0 mM, 
1.5 mM and 2.0 mM 
 
From the toolbar, select Compute (green equal sign) 
 
 
Postprocessing 
 
COMSOL should automatically produce both 2D and 3D solutions which can be found in 
the Results tab in the Model Builder.  If they are not automatically produced, follow the 
below directions as examples of possible result graphics. 
 
 
To see the 2D velocity profile: 
From the Model Builder window, right-click Results and select 2D Plot Group 
From the Model Builder window, right-click 2D Plot Group 1 and select Rename 
Change the name to Velocity and press OK 
From the Model Builder window, right-click Velocity and select Surface 
In the Settings window, select Plot (rainbow and pencil at top) 
Minimize the Velocity menu 
 
To see the 3D velocity profile: 
From the Model Builder window, right-click Results and select 3D Plot Group 
From the Model Builder window, right-click 3D Plot Group 1 and select Rename 
Change the name to Velocity and press OK 
From the Model Builder window, right-click Velocity and select Surface 
In the Settings window, select Plot (rainbow and pencil at top) 
Minimize the Velocity menu 
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To see the 2D concentration profile: 
From the Model Builder window, right-click Results and select 2D Plot Group 
From the Model Builder window, right-click 2D Plot Group 1 and select Rename 
Change the name to Concentration and press OK 
From the Model Builder window, right-click Concentration and select Surface 
In the Settings window, under Expression, select Replace Expression (green and 
orange triangles) 
Select Transport of Diluted Species>Species c>Concentration (c) 
In the Settings window, select Plot (rainbow and pencil at top) 
Minimize the Concentration menu 
 
To see the 3D concentration profile: 
From the Model Builder window, right-click Results and select 3D Plot Group 
From the Model Builder window, right-click 3D Plot Group 1 and select Rename 
Change the name to Concentration and press OK 
From the Model Builder window, right-click Concentration and select Surface 
In the Settings window, under Expression, select Replace Expression (green and 
orange triangles) 
Select Transport of Diluted Species>Species c>Concentration (c) 
In the Settings window, select Plot (rainbow and pencil at top) 
Minimize the Concentration menu 
 
To change which value of c0P is shown (for any graphic): 
From the Model Builder window, select Concentration 
In the Settings window, under Data, select the desired c0P from the Parameter Value 
drop down menu 
In the Settings window, select Plot (rainbow pencil near top) 
 
To find the concentration of glucose at the outlet of the Perfusate: 
From the Model Builder window, right-click Results>Derived Values and select 
Average>Line Average 
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the 
right-click it 
In the Settings window, the Boundary Selection list should now contain: 6 
In the Settings window, under Expression, select Replace Expression (green and 
orange triangles) 
Select Transport of Diluted Species>Species c>Concentration (c) 
Select Evaluate (New Table) (orange equal sign at top)  
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Creating a CMA-12 Brain Probe 
 
Space Dimension: 2D axisymmetric 
Physics: Creeping Flow (spf), Transport of Diluted Species (chds) 
Study: Stationary (Preset for Selected Physics) 
 
Parameters 
Add these under global definitions 
 
Name Expression Description (optional) 
V 1.67e-11 [m^3/s] Volumetric flow rate, perfusate 
rhoP 990 [kg/m^3] Density, perfusate 
etaP 7.28e-4 [kg/(m*s)] Dynamic viscosity, perfusate 
c0P 0.5 [mol/m^3] Initial concentration, perfusate 
c0B 1.25 [mol/m^3] Initial concentration, brain 
cC 1.25 [mol/m^3] Concentration in sampling fluid 
DP 8.3e-10 [m^2/s] Diffusion coefficient, perfusate 
DM 7.62e-11 [m^2/s] Diffusion coefficient, membrane 
DB 1.16e-10 [m^2/s] Diffusion coefficient, brain 
 
Geometry 
Length Unit: μm 
Geometries: 
 
Perfusate (r1) 
   Shape: rectangle 
   Width: 85 
   Height: 3000 
   Base: Corner 
 r: 125 
 z: 0 
Membrane (r2) 
   Shape: rectangle 
   Width: 40 
   Height: 3000 
   Base: Corner 
 r: 210  
 z: 0 
Side of Brain (r3) 
   Shape: rectangle 
   Width: 50 
   Height: 3025 
   Base: Corner 
 r: 250  
 z: -25 
Bottom of Brain (r4) 
   Shape: rectangle 
   Width: 300  
   Height: 50 
   Base: Corner 
 r: 0  
 z: -75
 
Create a Boolean Union between r3 and r4.  Do NOT keep Interior Boundaries 
 
Finalize the geometry with Form a Union  
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B-89 
 
Physics 
 
Creeping Flow (domain 2): 
  Compressibility: Incompressible flow 
 Fluid Properties: 
  Density: User defined: “rhoP” 
  Dynamic viscosity: User defined: “etaP” 
 Inlet (boundary 5): 
  Boundary Condition: Laminar Inlow 
  Laminar Inflow: Flow rate 
  Flow rate: “V” 
  Entrance length: “0” 
  Constrain endpoints to zero: √ 
 Outlet (boundary 6): 
  Boundary Condition: Pressure, no viscous stress 
  Pressure: “0” 
 
Transport of Diluted Species (domains 1,2,3) 
  Convection: √ 
 Convection and Diffusion 1: 
  Velocity field: Velocity field (spf/fp1) 
  Diffusion coefficient: User defined: “DP” 
 Initial Values 1: 
  Concentration: “c0P” 
 Inflow 1 (boundary 5): 
  c0,c: “c0P” 
 Outflow 1 (boundary 6) 
 Convection and Diffusion 2 (domain 3): 
  Velocity field:   “0” r 
    “0” z 
  Diffusion coefficient: User defined: “DM” 
 Convection and Diffusion 3 (domain 1): 
  Velocity field:   “0” r 
    “0” z 
  Diffusion coefficient: User defined: “DB”  
 Initial Values 2 (domain 1): 
  Concentration: “c0B” 
 Concentration 1 (boundaries 2,13,14): 
  Species c: √ 
  c0,c: “cC”  
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Mesh 
 
Sequence type: Physics-controlled mesh 
Element size: Normal 
 
 
Solving 
 
If using model for ZNF, use a Parametric Sweep to vary c0P 
 
 
Postprocessing 
 
COMSOL should automatically plot 2D and 2D results for both velocity and 
concentration. 
 
To determine outlet analyte concentration: 
Select the following boundary: 6 
Create a Line Average from Results>Derived Values>Averages 
Change the Expression to Transport of Diluted Species>Species c>Concentration (c) 
.
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Creating a Microdialysis Probe 
This is to be used when you are working with a probe that has the same basic structure as 
the CMA-12 but different dimensions, ie. a CMA-10 
 
These instructions are to be used in conjunction with another instruction.  Start in the 
other instructions, set up the basic physics, and when you get to the Parameters section, 
start here. 
 
Parameters 
Add these under global definitions.  The following values are for a CMA-12 probe and 
should be adjusted for the appropriate system. 
 
Name Expression Description (optional) 
V 1.67e-11 [m^3/s] Volumetric flow rate, perfusate 
rhoP 990 [kg/m^3] Density, perfusate 
etaP 7.28e-4 [kg/(m*s)] Dynamic viscosity, perfusate 
c0P 0.5 [mol/m^3] Initial concentration, perfusate 
c0B 1.25 [mol/m^3] Initial concentration, brain 
cC 1.25 [mol/m^3] Concentration in sampling fluid 
DP 8.3e-10 [m^2/s] Diffusion coefficient, perfusate 
DM 7.62e-11 [m^2/s] Diffusion coefficient, membrane 
DB 1.16e-10 [m^2/s] Diffusion coefficient, brain 
wa 8.5e-5 [m] Width of annulus, active region of probe 
hM .003 [m] Membrane height 
off 1.25e-4 [m] Distance inner wall of annulus if from center of probe 
wM 4e-5 [m] Membrane width 
 
Geometry 
Length Unit: μm 
Geometries: 
 
Perfusate (r1) 
   Shape: rectangle 
   Width: wa 
   Height: hM 
   Base: Corner 
x: off 
y: 0 
Membrane (r2) 
   Shape: rectangle 
   Width: wM 
   Height: hM 
   Base: Corner 
 x: off+wa  
 y: 0 
Side of Brain (r3) 
   Shape: rectangle 
   Width: wB 
   Height: wB+base 
   Base: Corner 
        x: off+wa+wM  
        y: -base 
Bottom of Brain (r4) 
   Shape: rectangle 
   Width: off+wa+wM+wB 
   Height: wB 
   Base: Corner 
 x: 0  
 y: -base-wB 
 
Create a Boolean Union between r3 and r4.  Do NOT keep Interior Boundaries 
Finalize the geometry with Form a Union 
Now continue with the other instructions starting at Perfusate Settings
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  Sensitivity Data   
            
            
  In all analyses, Cin = 0.5 mM   
  Sensitivity of Outlet Glucose Concentration to:   
            
            
  Inlet Flow Rate   
  % off norm V (m
3
/s) Co (mM) % c off norm   
  10 1.67E-12 1.196371648 175.3   
  50 8.35E-12 0.819496487 120.1   
  67 1.12E-11 0.754872636 110.6   
  91 1.52E-11 0.697953383 102.2   
  95 1.59E-11 0.690837086 101.2   
  99 1.65E-11 0.684213152 100.2   
  100 1.67E-11 0.682628216 100.0   
  101 1.69E-11 0.681070261 99.8   
  105 1.75E-11 0.675095027 98.9   
  110 1.84E-11 0.668157966 97.9   
  150 2.51E-11 0.627697607 92.0   
  200 3.34E-11 0.598220227 87.6   
  1000 1.67E-10 0.521500262 76.4   
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  Sensitivity Data   
            
            
  In all analyses, Cin = 0.5 mM   
  Sensitivity of Outlet Glucose Concentration to:   
            
            
  Brain Width   
  % off norm wB (µm) Co (mM) % c off norm   
  10 5.0 0.760106855 111.4   
  50 25.0 0.71727512 105.1   
  67 33.5 0.703741017 103.1   
  91 45.5 0.687821859 100.8   
  95 47.5 0.685466335 100.4   
  99 49.5 0.68318767 100.1   
  0 50.0 0.682628223 100.0   
  101 50.5 0.682095834 99.9   
  105 52.5 0.679913196 99.6   
  110 55.0 0.677261851 99.2   
  150 75.0 0.659318232 96.6   
  200 100.0 0.642652459 94.1   
  1000 500.0 0.571224998 83.7   
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  Sensitivity Data   
            
            
  In all analyses, Cin = 0.5 mM   
  Sensitivity of Outlet Glucose Concentration to:   
            
            
  Diffusion Coefficient in Brain   
  % off norm DB (m
2
/s) Co (mM) % c off norm   
  10 1.16E-11 0.545311844 79.9   
  50 5.80E-11 0.636711234 93.3   
  67 7.77E-11 0.656719474 96.2   
  91 1.06E-10 0.67676442 99.1   
  95 1.10E-10 0.679460428 99.5   
  99 1.15E-10 0.68201167 99.9   
  0 1.16E-10 0.682628216 100.0   
  101 1.17E-10 0.683236593 100.1   
  105 1.22E-10 0.685591572 100.4   
  110 1.28E-10 0.688369632 100.8   
  150 1.74E-10 0.705589725 103.4   
  200 2.32E-10 0.719357181 105.4   
  1000 1.16E-09 0.761218841 111.5   
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  Sensitivity Data   
            
            
  In all analyses, Cin = 0.5 mM   
  Sensitivity of Outlet Glucose Concentration to:   
            
            
  Diffusion Coefficient in Membrane   
  % off norm DM (m
2
/s) Co (mM) % c off norm   
  10 7.62E-12 0.53357684 78.2   
  50 3.81E-11 0.622428341 91.2   
  67 5.11E-11 0.647126927 94.8   
  91 6.93E-11 0.674121608 98.8   
  95 7.24E-11 0.67804422 99.3   
  99 7.54E-11 0.6816836 99.9   
  0 7.62E-11 0.682629269 100.0   
  101 7.70E-11 0.683564803 100.1   
  105 8.00E-11 0.686985485 100.6   
  110 8.38E-11 0.691129452 101.2   
  150 1.14E-10 0.718040094 105.2   
  200 1.52E-10 0.741566103 108.6   
  1000 7.62E-10 0.824792021 120.8   
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  Sensitivity Data   
            
            
  In all analyses, Cin = 0.5 mM   
  Sensitivity of Outlet Glucose Concentration to:   
            
            
  Diffusion Coefficient in Perfusate   
  % off norm DP (m
2
/s) Co (mM) % c off norm   
  10 8.30E-11 0.644430147 94.4   
  50 4.15E-10 0.676519387 99.1   
  67 5.56E-10 0.679560704 99.6   
  91 7.55E-10 0.682005735 99.9   
  95 7.89E-10 0.68229671 100.0   
  99 8.22E-10 0.682564558 100.0   
  0 8.30E-10 0.682628216 100.0   
  101 8.38E-10 0.682690626 100.0   
  105 8.72E-10 0.682928469 100.0   
  110 9.13E-10 0.683201525 100.1   
  150 1.25E-09 0.684721967 100.3   
  200 1.66E-09 0.68573044 100.5   
  1000 8.30E-09 0.68626844 100.5   
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  Sensitivity Data   
            
            
  In all analyses, Cin = 0.5 mM   
  Sensitivity of Outlet Glucose Concentration to:   
            
            
  Perfusate Density   
  % off norm rhoP (kg/m
3
) Co (mM) % c off norm   
  10 99.0 0.682628223 100.0   
  50 495.0 0.682628195 100.0   
  67 663.3 0.682628026 100.0   
  91 900.9 0.682628058 100.0   
  95 940.5 0.682628203 100.0   
  99 980.1 0.682628215 100.0   
  0 990.0 0.682628216 100.0   
  101 999.9 0.682628216 100.0   
  105 1039.5 0.682628216 100.0   
  110 1089.0 0.682628216 100.0   
  150 1485.0 0.682628216 100.0   
  200 1980.0 0.682628216 100.0   
  1000 9900.0 0.682628216 100.0   
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 Sensitivity Analysis Data 
 
            
  Sensitivity Data   
            
            
  In all analyses, Cin = 0.5 mM   
  Sensitivity of Outlet Glucose Concentration to:   
            
            
  Perfusate Viscosity   
  % off norm etaP (Pa*s) Co (mM) % c off norm   
  10 7.28E-05 0.682628216 100.0   
  50 3.64E-04 0.682628216 100.0   
  67 4.88E-04 0.682628216 100.0   
  91 6.62E-04 0.682628216 100.0   
  95 6.92E-04 0.682628216 100.0   
  99 7.21E-04 0.682628216 100.0   
  0 7.28E-04 0.682628216 100.0   
  101 7.35E-04 0.682628216 100.0   
  105 7.64E-04 0.682628216 100.0   
  110 8.01E-04 0.682628216 100.0   
  150 1.09E-03 0.682628216 100.0   
  200 1.46E-03 0.682628216 100.0   
  1000 7.28E-03 0.682628216 100.0   
            
            
0.683 
0.683 
0.683 
0.683 
0.683 
0.683 
0.683 
0.683 
0.683 
0.00E+00 1.00E-03 2.00E-03 3.00E-03 4.00E-03 5.00E-03 6.00E-03 7.00E-03 8.00E-03 
O
u
tl
e
t 
G
lu
co
se
 C
o
n
ce
n
tr
at
io
n
 (
m
M
) 
Dynamic Viscosity (Pa*s) 
 Appendix G 99 
 Transient Model 
 
Creating a Transient CMA-12 Brain-Probe System 
For those not familiar with COMSOL 4.2 
 
Open COMSOL 4.2 
From the Model Wizard window, select 2D axisymmetric and press next (light blue 
arrow) 
From the Add Physics tree, select Fluid Flow>Single-Phase Flow>Creeping Flow (spf) 
Click the Add Selected button at the bottom (light blue plus sign) 
From the Add Physics tree, select Chemical Species Transport>Transport of Diluted 
Species (chds) 
Press the Add Selected button, the press next 
From the Studies tree, select Preset Studies for Selected Physics>Time Dependent 
Press Finish (checkered flag) to start modeling 
 
In the Model Builder window, right-click Global Definitions and choose Parameters 
Go to the Settings window for Parameters 
In the Parameters table, enter the following settings (the name column is case sensitive) 
 
Name Expression Description (optional) 
V 1.67e-11 [m^3/s] Volumetric flow rate, perfusate 
rhoP 990 [kg/m^3] Density, perfusate 
etaP 
7.28e-4 
[kg/(m*s)] 
Dynamic viscosity, perfusate 
c0P 0.5 [mol/m^3] Initial concentration, perfusate 
c0B 1.25 [mol/m^3] Initial concentration, brain 
cC 1.25 [mol/m^3] Concentration in sampling fluid 
DP 8.3e-10 [m^2/s] Diffusion coefficient, perfusate 
DM 7.62e-11 [m^2/s] Diffusion coefficient, membrane 
DB 1.16e-10 [m^2/s] Diffusion coefficient, brain 
 
(If you intend to make any more models in the future, it may be beneficial to save your 
parameters as a text file.  You can do this by selecting the Save to file button (looks like a 
floppy disk) located under the parameters table.) 
 
In the Model Builder window, right-click Global Definitions and choose 
Functions>Piecewise 
From the Model Builder window, right-click Piecewise 1 (pw1) and select Rename 
F2 is the shortcut key for renaming an item. 
Change the name to Vstep and press OK 
From the Model Builder window, select Vstep (pw1) 
In the Settings window, under Function, enter “Vstep” into the Function name edit 
field 
In the Settings window, under Parameters, enter “t” into the Argument edit field 
In the Settings window, under Parameters, change Smoothing to Continuous Function 
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In the Settings window, under Parameters, enter “0.01” into the Relative Size of 
Transition Zone edit field 
In the Settings window, under Parameters, enter the following into the Intervals table 
 
Start End Function 
0 0.01 0 
0.01 1000 V 
 
This creates the initial ramping up of the perfusate flow. 
In the Model Builder window, right-click Global Definitions and choose 
Functions>Piecewise 
From the Model Builder window, right-click Piecewise 2 (pw2) and select Rename 
Change the name to cBstep and press OK 
From the Model Builder window, select cBstep (pw2) 
In the Settings window, under Function, enter “cBstep” into the Function name edit 
field 
In the Settings window, under Parameters, enter “t” into the Argument edit field 
In the Settings window, under Parameters, change Smoothing to Continuous Function 
In the Settings window, under Parameters, enter “0.01” into the Relative size of 
transition zone edit field 
In the Settings window, under Parameters, enter the following into the Intervals table 
Start End Function 
0 250 c0B 
250 500 1 
500 1000 c0B 
This creates a step function in the brain concentration.  The “dip” constitutes a thought, 
i.e. more glucose is being consumed. 
 
Modeling the System 
From the Model Builder window, select Geometry 1  
In the Settings window for Geometry, change the Length Unit from m to µm 
From the Model Builder window, right-click Geometry 1 and choose Rectangle 
In the Settings window for Rectangle, enter the following dimensions: 
Width: 85  
 Height: 3000 
 Base: Corner 
  r: 125  
  z: 0 
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From the Model Builder window, right-click Geometry 1 and choose Rectangle 
In the Settings window for Rectangle, enter the following dimensions: 
Width: 40  
 Height: 3000 
 Base: Corner 
  r: 210  
  z: 0 
 
From the Model Builder window, right-click Geometry 1 and choose Rectangle 
In the Settings window for Rectangle, enter the following dimensions: 
Width: 50  
 Height: 3025 
 Base: Corner 
  r: 250  
  z: -25 
 
From the Model Builder window, right-click Geometry 1 and choose Rectangle 
In the Settings window for Rectangle, enter the following dimensions: 
Width: 300  
 Height: 50 
 Base: Corner 
  r: 0  
  z: -75 
 
From the Model Builder window, right-click Geometry 1 and choose Boolean 
Operation>Union 
In the Graphics window, left-click on the right most rectangle (r3) (the domain should 
turn red) and then right-click the same rectangle (the domain should turn blue and 
is now added to the Input objects list in the Settings window).  Repeat this step 
for r4, the lowest rectangle. 
The Input objects list should now contain: r3 and r4 
Uncheck the Keep interior boundaries box 
 
From the Model Builder window, select Form Union 
In the Settings window for Finalize, select Build Selected (the light blue skyscraper with 
red box, near the top) 
 
In the Model Builder window, minimize the Geometry 1 menu (white downward arrow 
head next to  Geometry 1) 
 
You now have a 2D representation of the brain-probe system that will produce accurate 
results.  The inner (left most) rectangle is the perfusate domain.  Fluid will come in from 
the bottom and exit to top.  The middle rectangle is the membrane.  And the backwards-L-
shaped domain is the brain.  When solving, COMSOL will “wrap” this 2D section 
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around the r=0 axis (red dashed line) to form a 3D cylinder.  We can use the 2D 
axisymmetric model because the system is angle independent.  Now you will assign 
domain and boundary conditions to the geometry. 
 
Perfusate Settings 
 
From the Model Builder window, select Creeping Flow 
In the Settings window, use the control button on your keyboard to simultaneously select 
the following Domains: 1, 3 
Press the Remove from Selection button (light blue minus sign to the right of the 
selection field) 
You may have to scroll the Settings window over to see the button. 
In the Settings window, the Domain Selection list should now contain: 2 
In the Settings window, under Physical Model, change Compressibility to 
Incompressible flow 
 
Expand the Creeping Flow menu by clicking the rightward facing arrow next to 
Creeping Flow 
From the Model Builder window, select Creeping Flow>Fluid Properties 1 
In the Settings window, change Density to User defined and enter “rhoP” into the edit 
field (do not include the quotation marks) 
In the Settings window, change Dynamic viscosity to User defined and enter “etaP” into 
the edit field 
You have just assigned conditions of incompressible creep fluid flow to the probe. We do 
not do this for the other parts of the model because the brain and membrane do not 
contain fluid flow.  The next step is assigning the boundary conditions governing the flow 
of the perfusate.  
 
From the Model Builder window, right-click Creeping Flow and select Inlet 
In the Graphics window, left-click the bottom boundary of r1 (the perfusate domain) and 
then right-click 
In the Settings window, the Boundary Selection list should now contain: 5 
In the Settings window, under Boundary Conditions, change Boundary Condition to 
Laminar inflow 
Under Laminar Inflow, select Flow rate and then enter “Vstep(t)” into the V0 edit field 
The entry will remain orange, that is OK. 
Enter “0” into the Lentr edit field and select the box next to Constrain endpoints to zero 
 
From the Model Builder window, right-click Creeping Flow and select Outlet 
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the 
right-click it 
In the Settings window, the Boundary Selection list should now contain: 6 
 
Minimize the Creeping Flow menu 
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Expand the Transport of Diluted Species menu 
 
From the Model Builder window, right-click Convection and Diffusion 1 and select 
Rename 
Change the name to Perfusate and press OK  
In the Settings window, under Model Inputs, change the Velocity field to Velocity 
Field (spf/fp1) 
In the Settings window, under Diffusion, enter “DP” into the Diffusion coefficient edit 
field 
 
From the Model Builder window, right-click Initial Values 1 and select Rename 
Change the name to Initial Perf/Memb Values and press OK 
In the Settings window, under Initial, enter “c0P” into the Concentration edit field 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Inflow 
In the Graphics window, left-click the bottom boundary of r1 (the perfusate domain) and 
then right-click 
In the Settings window, the Boundary Selection list should now contain: 5 
In the Settings window, under Concentration, enter “c0P” into the c0,c edit field 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Outflow 
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the 
right-click it 
In the Settings window, the Boundary Selection list should now contain: 6 
 
 
 
Membrane Settings 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Convection and Diffusion 
From the Model Builder window, right-click Convection and Diffusion 2 and select 
Rename 
Change the name to Membrane and press OK 
In the Graphics window, left-click the middle rectangle (r2) and then right-click it 
In the Settings window, the Boundary Selection list should now contain: 3 
In the Settings window, under Diffusion, enter “DM” into the Diffusion coefficient edit 
field 
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Brian Settings 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Convection and Diffusion 
From the Model Builder window, right-click Convection and Diffusion 3 and select 
Rename 
Change the name to Brain and press OK 
In the Graphics window, left-click the backwards-L-shaped domain and then right-click 
it 
In the Settings window, the Boundary Selection list should now contain: 1 
In the Settings window, under Diffusion, enter “DB” into the Diffusion coefficient edit 
field 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Initial Values 
From the Model Builder window, right-click Initial Values 2 and select Rename 
Change the name to Initial Brain Values and press OK 
In the Graphics window, left-click the backwards-L-shaped domain and then right-click 
it 
In the Settings window, the Boundary Selection list should now contain: 1 
In the Settings window, under Initial, enter “c0B” into the Concentration edit field 
 
From the Model Builder window, right-click Transport of Diluted Species and select 
Concentration 
In the Graphics window, alternatively left- and right-click the two right most and the 
lowest boundary and then right-click them (the second right most boundary is 
small and at the bottom) 
In the Settings window, the Boundary Selection list should now contain: 2, 13 and 14 
In the Settings window, under Concentration, select the box next to Species c and enter 
“cBstep(t)” into the c0,c edit field 
The entry will remain orange, that is OK. 
 
Minimize the Transport of Diluted Species menu 
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Mesh 
 
Now you have set up all the physics governing the system. Next, a mesh must be created 
which COMSOL will solve the equations over and then solve the problem.  Fortunately, 
COMSOL has suggested meshes for certain physics and geometries.  The suggestion 
works for our case and is the default mesh; so you do not have to do anything. 
 
From the Model Builder window, select Mesh 1 
In the Settings window, make sure the Sequencing type reads Physics-controlled mesh 
and the Element size is Normal 
 
 
Solving 
 
In the Settings window, under Study Settings, enter “range(0,1,750)” into the Times edit 
field 
 
From the toolbar, select Compute (green equal sign) 
 
Postprocessing 
 
COMSOL should automatically produce both 2D and 3D solutions which can be found in 
the Results tab in the Model Builder.  If they are not automatically produced, follow the 
below directions as examples of possible result graphics. 
 
To see the 2D velocity profile: 
From the Model Builder window, right-click Results and select 2D Plot Group 
From the Model Builder window, right-click 2D Plot Group 1 and select Rename 
Change the name to Velocity and press OK 
From the Model Builder window, right-click Velocity and select Surface 
In the Settings window, select Plot (rainbow and pencil at top) 
Minimize the Velocity menu 
 
To see the 3D velocity profile: 
From the Model Builder window, right-click Results and select 3D Plot Group 
From the Model Builder window, right-click 3D Plot Group 1 and select Rename 
Change the name to Velocity and press OK 
From the Model Builder window, right-click Velocity and select Surface 
In the Settings window, select Plot (rainbow and pencil at top) 
Minimize the Velocity menu 
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To see the 2D concentration profile: 
From the Model Builder window, right-click Results and select 2D Plot Group 
From the Model Builder window, right-click 2D Plot Group 1 and select Rename 
Change the name to Concentration and press OK 
From the Model Builder window, right-click Concentration and select Surface 
In the Settings window, under Expression, select Replace Expression (green and 
orange triangles) 
Select Transport of Diluted Species>Species c>Concentration (c) 
In the Settings window, select Plot (rainbow and pencil at top) 
Minimize the Concentration menu 
 
To see the 3D concentration profile: 
From the Model Builder window, right-click Results and select 3D Plot Group 
From the Model Builder window, right-click 3D Plot Group 1 and select Rename 
Change the name to Concentration and press OK 
From the Model Builder window, right-click Concentration and select Surface 
In the Settings window, under Expression, select Replace Expression (green and 
orange triangles) 
Select Transport of Diluted Species>Species c>Concentration (c) 
In the Settings window, select Plot (rainbow and pencil at top) 
Minimize the Concentration menu 
 
To change which value of c0P is shown (for any graphic): 
From the Model Builder window, select Concentration 
In the Settings window, under Data, select the desired c0P from the Parameter Value 
drop down menu 
In the Settings window, select Plot (rainbow pencil near top) 
 
To find the concentration of glucose at the outlet of the Perfusate: 
From the Model Builder window, right-click Results>Derived Values and select 
Average>Line Average 
In the Graphics window, left-click the top boundary of r1 (the perfusate domain) and the 
right-click it 
In the Settings window, the Boundary Selection list should now contain: 6 
In the Settings window, under Expression, select Replace Expression (green and 
orange triangles) 
Select Transport of Diluted Species>Species c>Concentration (c) 
Select Evaluate (New Table) (orange equal sign at top) 
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%Damon Vinciguerra  Thesis  Taylor Dispersion 
clc 
clear all 
close all 
home 
  
%% General Parameters 
V = 1.67e-11;           % m^3/s, Volumetric flow rate of dialysate 
L = 2;                  % m, Lenght of tubing 
R = 0.0001075;          % m, inner radius of tubing 
eta = 7.28e-4;          % Pa*s, viscosity of perfusate 
D = 8.3e-10;            % m^2/s, diffusivity of glucose through 
perfusate 
vzavg = V/(pi*R^2);     % m/s, Velocity of dialysate 
  
K = D+((R*vzavg)^2)/(48*D);     % m^2/s, mass transfer coefficient 
Re = vzavg*2*R*990/eta;         % Reynolds number 
Per = R*vzavg/D;                % Peclet number, radial 
Pea = L*vzavg/K;                % Peclet number, axial 
  
%% Domains - Boltzmann Sigmoidal 
ex = 1000;                      % s, Excess on ends to cusion test 
tth = 250;                      % s, Duration of thought 
tfin = ex + tth + ex;           % s, Total time of simulation 
ts = 100000;                    % Time steps 
tD = linspace(0,tfin/2+1,ts/2);   % s, Domain for concnetration drop 
dt = tD(2)-tD(1); 
tI = linspace(tfin/2+dt,tfin,ts/2);  % s, Domain for concentration 
increase 
t = [tD tI]; 
Dt50 = ex ;             % s, Time at which drop is half way betwen T 
and B 
It50 = ex + tth;             % s, Time at which increase is half way 
betwen B and T 
  
z1 = Dt50*vzavg; 
z2 = It50*vzavg; 
tout=L/vzavg; 
  
%% Signal - Boltzmann Sigmoidal Approximation 
T = 0.6826;             % mM, Upper limit (Normal dialysate 
concentration) 
B = 0.6217;             % mM, Lower limit (Affected dialysate 
concntration) 
m = 6.6;                % mM/s, slope at t50 
  
xD = B+((T-B)./(1+exp((Dt50-tD)./-m)));       % mM, Signal for drop 
xI = B+((T-B)./(1+exp((It50-tI)./m)));        % mM, Signal for 
dincrease 
x = [xD xI]; 
  
subplot(2,2,1) 
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plot(t,x) 
ylabel('x(t)','FontSize',12) 
xlabel('Time (s)','FontSize',12) 
title('Signal: x(t)','FontSize',12) 
axis([0 tfin .6 .7]) 
  
%% Smearing function: (1/sqrt(4*pi*k*t))*exp(L) 
sig2 = 2.*K.*tout;      % Square of standard deviation 
sig = sqrt(sig2);       % Standard deviation 
Ng = 1001; 
N = (Ng-1)/2; 
dy = 10*sig/Ng;    % Number of points to trace out the curve (+/- 
5*sig) 
  
zf = dy*(-N:N);                             % time base for smearing 
function 
f = exp(-((-zf).^2)./(2.*sig2))./sqrt(2.*pi.*sig2);     % smearing 
function, Normal Distribution 
  
subplot(2,2,2) 
plot(zf,f) 
xlabel('z-y','FontSize',12) 
ylabel('f(z)','FontSize',12) 
title('Smearing function: f(z)','FontSize',12) 
  
%% Compute convolution - Boltzmann Sigmoidal 
Nz = round(vzavg*tfin/dy); 
zz = dy*(0:Nz); 
mz = m*vzavg;           % mM/m, slope at t50 
  
zzD = zz(1:floor(end/2)); 
zzI = zz(floor(end/2)+1:end); 
xsD = B+((T-B)./(1+exp((z1-zzD)./-mz)));       % mM, Signal for drop 
xsI = B+((T-B)./(1+exp((z2-zzI)./mz)));        % mM, Signal for 
dincrease 
xs = [xsD xsI]; 
  
xc = conv(xs,f,'full');          % Convolution of signal with smearing 
function 
tc = dy*(0:length(xc)-1); 
tau = dy*length(f)/2;     % offset for filter width 
  
g = (tc-tau)./vzavg; 
y = xc/max(xc)*max(x); 
  
subplot(2,1,2) 
plot(t,x,'b',g(2*N:end-(2*N-1)),y(2*N:end-(2*N-1)),'--r') 
axis([0 tfin .6 .7]) 
ylabel('y(t)','FontSize',12) 
xlabel('Time (s)','FontSize',12) 
title('Output signal: y(t) = f(z/v)*x(t)','FontSize',12) 
legend('Signal','Output','Location','SouthEast') 
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%% Width of dispersion in signal 
er = 0.1;                   % Allowable deviation from steady state 
  
if min(x) < B + (T-B)*er 
    sigD = T; 
    k = 0; 
    while sigD > T - (T-B)*er 
        k = k + 1; 
        sigD = xD(k); 
    end 
    tDsT = tD(k); 
  
    while sigD > B + (T-B)*er 
        k = k + 1; 
        sigD = xD(k); 
    end 
    tDsB = tD(k); 
  
    wsig = tDsB - tDsT;         % Width of signal change 
    disp(['width of signal- ',num2str(wsig),' s (',num2str(wsig/60),' 
min)']) 
else 
    sigD = T; 
    k = 0; 
    while sigD > T - (T-B)*er 
        k = k + 1; 
        sigD = xD(k); 
    end 
    tDsT = tD(k); 
    tDsB = tfin/2; 
     
    wsig = tDsB - tDsT;         % Width of signal change 
    disp(['width of signal- ',num2str(wsig),' s (',num2str(wsig/60),' 
min)']) 
end 
%% Width of Output 
if min(y(2*N:end-(2*N-1))) < B + (T-B)*er 
    testD = T; 
    k = 2*N; 
    while testD > T - (T-B)*er 
        k = k + 1; 
        testD = y(k); 
    end 
    tDoT = g(k); 
  
    while testD > B + (T-B)*er 
        k = k + 1; 
        testD = y(k); 
    end 
    tDoB = g(k); 
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    wout = tDoB - tDoT;         % Width of output 
    disp(['Width of Output- ',num2str(wout),' s (',num2str(wout/60),' 
min)']) 
else 
    testD = T; 
    k = 2*N; 
    while testD > T - (T-B)*er 
        k = k + 1; 
        testD = y(k); 
    end 
    tDoT = g(k); 
    tDoB = tfin/2; 
     
    wout = tDoB - tDoT;         % Width of output 
    disp(['Width of Output- ',num2str(wout),' s (',num2str(wout/60),' 
min)']) 
end 
%% Extent of Broadening 
disp(' ') 
disp(['Increase in width- ',num2str(wout-wsig),' s (',num2str((wout-
wsig)/60),' min)']) 
  
%% Describing Broadenings 
mTextBox = uicontrol('style','text'); 
set(mTextBox,'String',['Width- ',num2str(wsig),' 
s'],'Position',[99,256,150,17],'FontSize',10) 
nTextBox = uicontrol('style','text'); 
set(nTextBox,'String',['Width- ',num2str(wout),' 
s'],'Position',[80,55,150,17],'FontSize',10) 
  
%% Fitting Output 
[coeffD,rD] = fit(g(2*N:floor(end/2))',y(2*N:floor(end/2))','a + (b - 
a) ./ (1 + exp((h - x)/m))','start',[0.62 0.68 1100 -6.6]); 
[coeffI,rI] = fit(g(floor(end/2)+1:end-(2*N-1))',y(floor(end/2)+1:end-
(2*N-1))','a + (b - a) ./ (1 + exp((h - x)/m))','start',[0.62 0.68 1900 
6.6]);
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%Damon Vinciguerra  Thesis  Taylor Dispersion 
clc 
clear all 
close all 
home 
 
%% General Parameters 
V = 1.67e-11;           % m^3/s, Volumetric flow rate of dialysate 
R = 0.0001075;          % m, inner radius of tubing 
eta = 7.28e-4;          % Pa*s, viscosity of perfusate 
D = 8.3e-10;             % m^2/s, diffusivity of glucose through 
perfusate 
vzavg = V/(pi*R^2);     % m/s, Velocity of dialysate 
  
K = D+((R*vzavg)^2)/(48*D);     % mass transfer coefficient 
Re = vzavg*2*R*990/eta;         % Reynolds number 
Per = R*vzavg/D;                % Peclet number, radial 
  
%% Domains - Boltzmann Sigmoidal 
ex = 1000;                      % s, Excess on ends to cusion test 
tth = 250;                      % s, Duration of thought 
tfin = ex + tth + ex;           % s, Total time of simulation 
ts = 100000;                    % Time steps 
tD = linspace(0,tfin/2+1,ts/2);   % s, Domain for concnetration drop 
dt = tD(2)-tD(1); 
tI = linspace(tfin/2+dt,tfin,ts/2);  % s, Domain for concentration 
increase 
t = [tD tI]; 
Dt50 = ex ;             % s, Time at which drop is half way betwen T 
and B 
It50 = ex + tth;             % s, Time at which increase is half way 
betwen B and T 
  
z1 = Dt50*vzavg; 
z2 = It50*vzavg; 
     
%% Signal - Boltzmann Sigmoidal Approximation 
T = 0.6826;             % mM, Upper limit (Normal dialysate 
concentration) 
B = 0.6217;             % mM, Lower limit (Affected dialysate 
concntration) 
m = 6.6;                % mM/s, slope at t50 
  
xD = B+((T-B)./(1+exp((Dt50-tD)./-m)));       % mM, Signal for drop 
xI = B+((T-B)./(1+exp((It50-tI)./m)));        % mM, Signal for 
dincrease 
x = [xD xI]; 
  
%% 
o = 0; 
for L = 0.01:0.01:2 
    o = o + 1; 
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    %% Smearing function: (1/sqrt(4*pi*k*t))*exp(L) 
    tout=L/vzavg; 
    sig2 = 2.*K.*tout;      % Square of standard deviation 
    sig = sqrt(sig2);       % Standard deviation 
    Ng = 1001; 
    N = (Ng-1)/2; 
    dy = 10*sig/Ng;    % Number of points to trace out the curve (+/- 
5*sig) 
  
    zf = dy*(-N:N);                             % time base for 
smearing function 
    f = exp(-((-zf).^2)./(2.*sig2))./sqrt(2.*pi.*sig2);     % smearing 
function, Normal Distribution 
     
    %% Compute convolution - Boltzmann Sigmoidal 
    Nz = round(vzavg*tfin/dy); 
    zz = dy*(0:Nz); 
    mz = m*vzavg;           % mM/m, slope at t50 
  
    zzD = zz(1:floor(end/2)); 
    zzI = zz(floor(end/2)+1:end); 
    xsD = B+((T-B)./(1+exp((z1-zzD)./-mz)));       % mM, Signal for 
drop 
    xsI = B+((T-B)./(1+exp((z2-zzI)./mz)));        % mM, Signal for 
dincrease 
    xs = [xsD xsI]; 
  
    xc = conv(xs,f,'full');          % Convolution of signal with 
smearing function 
    tc = dy*(0:length(xc)-1); 
    tau = dy*length(f)/2;     % offset for filter width 
  
    g = (tc-tau)./vzavg; 
    y = xc/max(xc)*max(x); 
        
    %% Width of Dispersion     
    er = 0.001;                   % Allowable deviation from steady 
state     
     
    if min(y(2*N:end-(2*N-1))) < B + (T-B)*er 
        testD = T; 
        k = 2*N; 
     
        while testD > T - (T-B)*er 
            k = k + 1; 
            testD = y(k); 
        end 
        tDoT = g(k); 
     
        while testD > B + (T-B)*er 
            k = k + 1; 
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            testD = y(k); 
        end 
        tDoB = g(k); 
  
        wdis(o) = tDoB - tDoT;         % Width of output 
    else 
        testD = T; 
        k = 2*N; 
        while testD > T - (T-B)*er 
            k = k + 1; 
            testD = y(k); 
        end 
        tDoT = g(k); 
         
        wdis(o) = tfin/2 - tDoT; 
    end 
     
    %% Width of Readable Signal 
    if min(y(2*N:end-(2*N-1))) < B + (T-B)*er 
        testS = T; 
        k = 2*N; 
     
        while testS > B + (T-B)*er 
            k = k + 1; 
            testS = y(k); 
        end 
        tSoU = g(k); 
        k = k + 1; 
     
        while testS < B + (T-B)*er 
            k = k + 1; 
            testS = y(k); 
        end 
        tSoB = g(k); 
  
        wsig(o) = tSoB - tSoU;         % Width of output     
    else 
        wsig(o) = 0; 
    end 
    %% Plotting 
    plot(t,x,'--b',g(2*N:end-(2*N-1)),y(2*N:end-(2*N-1)),'r') 
    axis([0 tfin .6 .7]) 
    ylabel('Concentration (mM)','FontSize',12) 
    xlabel('Time (s)','FontSize',12) 
    title('Comparison of Output (-) to Signal (- -)','FontSize',12) 
    format short 
    nTextBox = uicontrol('style','text'); 
    set(nTextBox,'String',['Distance Along Tube- ',num2str(L,3),' m 
','Width of Deviation- ',num2str(wsig(o)/60),' 
min'],'Position',[200,55,180,34],'FontSize',10) 
    drawnow 
end 
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title('Comparison of Output to Signal','FontSize',12) 
legend('Signal','Output') 
  
figure(2) 
plot(0.005:0.005:1,wsig./tth) 
title('Width of True Signal Concentration over Tube Length') 
xlabel('Length of Tubing (%)') 
ylabel('Width of Signal (% of initial)') 
  
figure(3) 
plot(0.005:0.005:1,wdis) 
title('Dispersion of Signal "Step" over Length of Tubing') 
xlabel('Length of Tubing (%)') 
ylabel('Extent of Broadening (s)')
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root(KL/v^3) MATLAB (s) Approximation (s) Error
/1000 130600 859829.6813 848850 -1%
/500 46179 303969.4128 300113.5 -1%
/200 11692 76748.5314 75948 -1%
/100 4145 27170.9758 26892.5 -1%
/50 1481.5 9693.9621 9579.75 -1%
/40 1068.6 6975.5339 6895.9 -1%
/30 705.9237 4586.9504 4538.50405 -1%
/20 402.0771 2586.355 2563.50115 -1%
/10 172.2414 1073.3724 1069.5691 0%
/5 91.8576 546.7489 547.0744 0%
/2 51.5636 283.2164 285.1634 1%
Nominal 35.5131 179.6789 180.83515 1%
*1.5 29.0834 138.6134 139.0421 0%
*2 25.154 114.1767 113.501 -1%
*5 15.8862 58.2856 53.2603 -9%
*10 11.231 33.1067 23.0015 -31%
*20 7.9411 17.7541 1.61715 -91%
*30 6.4838 12.0651 -7.8553 -165%
*40 5.6151 9.1429 -13.50185 -248%
*50 5.0223 7.3781 -17.35505 -335%
*100 3.5513 3.7038 -26.91655 -827%
*200 2.5112 1.8434 -33.6772 -1927%
*500 1.5882 0.74472 -39.6767 -5428%
*1000 1.123 0.3528 -42.7005 -12203%
slope
y-intercept
r-squared 0.999866556
-47.58237584
6.491702447
Fitting Dispersion Time
Line of best fit for highlighted data
Varying V
Change
y = 6.5841x - 74.118
R² = 1
0
200000
400000
600000
800000
1000000
0 20000 40000 60000 80000 100000 120000 140000
M
A
TL
A
B
root(KL/v^3)
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root(KL/v^3) MATLAB (s) Approximation (s) Error
/1000 1123 7333.5959 7249.5 -1%
/500 794.0978 5168.0614 5111.6357 -1%
/200 502.2316 3246.5162 3214.5054 -1%
/100 355.1315 2277.4571 2258.35475 -1%
/50 251.1164 1592.6579 1582.2566 -1%
/40 224.6057 1418.1205 1409.93705 -1%
/30 194.5149 1220.013 1214.34685 0%
/20 158.8222 985.025 982.3443 0%
/10 112.31 680.3912 680.015 0%
/5 79.4312 465.709 466.3028 0%
/2 50.308 274.8694 277.002 1%
Nominal 35.7525 181.3065 182.39125 1%
*1.5 29.4342 141.0439 141.3223 0%
*2 25.7818 117.8387 117.5817 0%
*5 18.3715 73.0282 69.41475 -5%
*10 17.2241 66.14 61.95665 -6%
*20 20.1039 83.3603 80.67535 -3%
*30 23.5308 103.9178 102.9502 -1%
*40 26.7159 123.928 123.65335 0%
*50 29.6309 142.3915 142.60085 0%
*100 41.4505 218.1099 219.42825 1%
*200 58.4582 328.3564 329.9783 0%
*500 92.3589 548.7221 550.33285 0%
*1000 130.6007 801.0696 798.90455 0%
slope
y-intercept
r-squared 0.999913226
Change
Fitting Dispersion Time
Varying Dp
Line of best fit for highlighted data
6.47294151
-48.21067885
y = 6.5747x - 54.345
R² = 1
0
2000
4000
6000
8000
0 500 1000 1500
M
A
TL
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B
root(KL/v^3)
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root(KL/v^3) MATLAB (s) Approximation (s) Error
/1000 -
/500 -
/200 -
/100 -
/50 -
/40 -
/30 -
/20 0.0166 0.013884 -49.8921 -359450%
/10 0.1311 0.020063 -49.14785 -245068%
/5 1.0457 0.33116 -43.20295 -13146%
/2 16.3269 60.9197 56.12485 -8%
Nominal 130.6007 801.6732 798.90455 0%
*1.5 440.7684 2841.864 2814.9946 -1%
*2 1044.8 6818.4451 6741.2 -1%
*5 16324 107414.894 106056 -1%
*10 130600 859798 848850 -1%
*20 -
*30 -
*40 -
*50 -
*100 -
*200 -
*500 -
*1000 -
slope
y-intercept
r-squared
Change
Fitting Dispersion Time
Varying R
Line of best fit for highlighted data
6.58374287
-41.17147965
0.999999993
y = 6.5839x - 57.029
R² = 1
0
200000
400000
600000
800000
1000000
0 50000 100000 150000
M
A
TL
A
B
root(KL/v^3)
 Appendix J 118 
 Data for the Vinciguerra number 
 
 
  
root(KL/v^3) MATLAB (s) Approximation (s) Error
/1000 4.13 5.6983 -23.155 -506%
/500 5.8406 10.5501 -12.0361 -214%
/200 9.2349 24.1517 10.02685 -58%
/100 13.0601 43.3256 34.89065 -19%
/50 18.4697 74.1218 70.05305 -5%
/40 20.6498 87.0355 84.2237 -3%
/30 23.8443 106.7504 104.98795 -2%
/20 29.2032 140.1012 139.8208 0%
/10 41.2996 217.7352 218.4474 0%
/5 58.4064 327.8266 329.6416 1%
/2 92.3487 550.5992 550.26655 0%
Nominal 130.6007 801.6732 798.90455 0%
*1.5 159.9526 993.0704 989.6919 0%
*2 184.6973 1158.8906 1150.53245 -1%
*5 292.0321 1862.636 1848.20865 -1%
*10 412.9958 2659.0186 2634.4727 -1%
*20 584.0642 3785.2736 3746.4173 -1%
*30 715.3296 4639.3733 4599.6424 -1%
*40 825.9915 5378.0388 5318.94475 -1%
*50 923.4866 6019.9124 5952.6629 -1%
*100 1306 8538.2952 8439 -1%
*200 1847 12099.8264 11955.5 -1%
*500 2920.3 19166.3746 18931.95 -1%
*1000 4130 27130.2003 26795 -1%
slope
y-intercept
r-squared 0.999997394
Fitting Dispersion Time
Varying L
Line of best fit for highlighted data
6.571225023
-55.80755791
Change
y = 6.5819x - 56.31
R² = 1
0
10000
20000
30000
0 1000 2000 3000 4000 5000
M
A
TL
A
B
root(KL/v^3)
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Change V (m3/s) COMSOL (s) L (m) COMSOL (s) Change D (m2/s) COMSOL (s)
/50 1.67E-14 - 0.010 90 /30 2.54E-12 -
/20 8.35E-13 252 0.004 50 /20 3.81E-12 52
/10 1.67E-12 193 0.003 42 /10 7.62E-12 56
/5 3.34E-12 121 0.002 34 /5 1.52E-11 51
/4.5 3.71E-12 112 0.001 24 /2 3.81E-11 45
/4 4.18E-12 103 Nominal 7.62E-11 42
/3.5 4.77E-12 93 *1.5 1.14E-10 41
/3 5.57E-12 84 *2 1.52E-10 40
/2.5 6.68E-12 74 *5 3.81E-10 39
/2 8.35E-12 64 *10 7.62E-10 38
/1.5 1.11E-11 53 *20 1.52E-09 38
Nominal 1.67E-11 42 *30 2.29E-09 38
*1.5 2.51E-11 34 *40 3.05E-09 38
*2 3.34E-11 30 *50 3.81E-09 38
*5 8.35E-11 18 *100 7.62E-09 37
*10 1.67E-10 10 *200 1.52E-08 37
*500 3.81E-08 37
*1000 7.62E-08 36
Fitting Time to Steady-State in Probe
Data
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40
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COMSOL (s) V (m3/s) L (m) D (m2/s) 1/root(vz) L 1/root(D) Constant Approximation (s) Deviation
252 8.35E-13 0.003 7.62E-11 327.3135068 0.003 114557.23 1 2.60E+02 3%
193 1.67E-12 0.003 7.62E-11 231.4456002 0.003 114557.23 1 1.78E+02 -8%
121 3.34E-12 0.003 7.62E-11 163.6567534 0.003 114557.23 1 1.21E+02 0%
112 3.71111E-12 0.003 7.62E-11 155.2584286 0.003 114557.23 1 1.14E+02 2%
103 4.175E-12 0.003 7.62E-11 146.3790502 0.003 114557.23 1 1.06E+02 3%
93 4.77143E-12 0.003 7.62E-11 136.9250636 0.003 114557.23 1 9.81E+01 5%
84 5.56667E-12 0.003 7.62E-11 126.7679761 0.003 114557.23 1 8.95E+01 7%
74 6.68E-12 0.003 7.62E-11 115.7228001 0.003 114557.23 1 8.01E+01 8%
64 8.35E-12 0.003 7.62E-11 103.505619 0.003 114557.23 1 6.97E+01 9%
53 1.11333E-11 0.003 7.62E-11 89.63849553 0.003 114557.23 1 5.79E+01 9%
42 1.67E-11 0.003 7.62E-11 73.18952512 0.003 114557.23 1 4.39E+01 5%
34 2.505E-11 0.003 7.62E-11 59.75899702 0.003 114557.23 1 3.25E+01 -4%
30 3.34E-11 0.003 7.62E-11 51.75280952 0.003 114557.23 1 2.57E+01 -14%
18 8.35E-11 0.003 7.62E-11 32.73135068 0.003 114557.23 1 9.55E+00 -47%
10 1.67E-10 0.003 7.62E-11 23.14456002 0.003 114557.23 1 1.40E+00 -86%
90 1.67E-11 0.01 7.62E-11 73.18952512 0.01 114557.23 1 9.29E+01 3%
50 1.67E-11 0.004 7.62E-11 73.18952512 0.004 114557.23 1 5.09E+01 2%
34 1.67E-11 0.002 7.62E-11 73.18952512 0.002 114557.23 1 3.69E+01 9%
24 1.67E-11 0.001 7.62E-11 73.18952512 0.001 114557.23 1 2.99E+01 25%
56 1.67E-11 0.003 7.62E-12 73.18952512 0.003 362261.78 1 5.63E+01 1%
51 1.67E-11 0.003 1.524E-11 73.18952512 0.003 256157.76 1 5.10E+01 0%
45 1.67E-11 0.003 3.81E-11 73.18952512 0.003 162008.39 1 4.63E+01 3%
41 1.67E-11 0.003 1.143E-10 73.18952512 0.003 93535.59 1 4.29E+01 5%
40 1.67E-11 0.003 1.524E-10 73.18952512 0.003 81004.20 1 4.23E+01 6%
39 1.67E-11 0.003 3.81E-10 73.18952512 0.003 51231.55 1 4.08E+01 5%
38 1.67E-11 0.003 7.62E-10 73.18952512 0.003 36226.18 1 4.00E+01 5%
38 1.67E-11 0.003 1.524E-09 73.18952512 0.003 25615.78 1 3.95E+01 4%
38 1.67E-11 0.003 2.286E-09 73.18952512 0.003 20915.19 1 3.93E+01 3%
38 1.67E-11 0.003 3.048E-09 73.18952512 0.003 18113.09 1 3.91E+01 3%
38 1.67E-11 0.003 3.81E-09 73.18952512 0.003 16200.84 1 3.90E+01 3%
37 1.67E-11 0.003 7.62E-09 73.18952512 0.003 11455.72 1 3.88E+01 5%
37 1.67E-11 0.003 1.524E-08 73.18952512 0.003 8100.42 1 3.86E+01 4%
37 1.67E-11 0.003 3.81E-08 73.18952512 0.003 5123.16 1 3.85E+01 4%
36 1.67E-11 0.003 7.62E-08 73.18952512 0.003 3622.62 1 3.84E+01 7%
V
L
D
Real Time
Fit is good for steady-state times greater than 30 s
This rounded version works just as well
tsteady-state = 0.85/sqrt(vz) + 7000*L + 5e-5/sqrt(D) - 45
Data from above Processed for MATLAB Results
Equation to approximate time to steady-state in the probe
tsteady-state = 0.8379/sqrt(vz) + 6949.1*L + 5.5867e-5/sqrt(D) - 45.4092
All three parameters (L, vz, D) and assessed individually
Multilinear Regression
